![]() |
![]() |
![]() |
![]() |
POS-002 | THE EFFECT OF ANG-3777 ON THE GROWTH OF C-MET-EXPRESSING HUMAN TUMOR CELLS IN IMMUNOCOMPROMISED MICE | Eric Krauter | ![]() |
![]() |
|||
POS-003 | TOTAL RNA FROM BONE MARROW CELLS INDUCES LIVER REGENERATION BY CO-ACTIVATING EARLY APOPTOSIS AND PROLIFERATION PROCESSES | Murat Shagidulin | ![]() |
![]() |
|||
POS-004 | TOWARD A BIO-ENGINEERED PERIOSTEUM | Julie Manon | ![]() |
![]() |
|||
POS-006 | THE COVID19 PANDEMIC IMPACT ON TISSUE DONATION, LESSONS LEARNED | Lucas Lozano | ![]() |
![]() |
|||
POS-007 | EX VIVO MACHINE PERFUSION TO ASSESS ISCHEMIA REPERFUSION INJURY OF AMPUTATED PORCINE LIMBS | Ahmed Fahiem Abdelsalam Emara | ![]() |
![]() |
|||
POS-008 | EVALUATION OF EPIDEMIOLOGICAL FEATURES OF PERMANENT HYPOPARATHYROIDISM PATIENTS WHILE AS A CANDIDATE OF PARATHYROID TRANSPLANTATION | Harika Salepcioglu Kaya | ![]() |
![]() |
|||
POS-010 | IMPROVING THE TECHNIQUE OF A HETEROTOPIC VASCULARIZED COMPOSITE HINDLIMB ALLOTRANSPLANTATION IN THE PIG | Stefanie Hirsiger | ![]() |
![]() |
|||
POS-011 | AUTOTRANSPLANTATION OF UTERUS ON ANIMAL MODEL PRELIMINARY TO CLINICAL APPLICATION | Emanuele Federico Kauffmann | ![]() |
![]() |
|||
POS-012 | NEW SURGICAL APPROACH TO USE HUMAN ALLOGRAFT AS BIOLOGICAL DRESSING IN PATIENTS WITH EPIDERMOLYSIS BULLOSA (EB) | Magdalena Nita | ![]() |
![]() |
|||
POS-013 | EFFICIENT RECELLULARIZATION OF HUMAN VASCULAR GRAFTS WITH PATIENT DERIVED ENDOTHELIAL CELLS | Hector Tejeda Mora | ![]() |
![]() |
|||
POS-015 | A SYSTEMATIC REVIEW OF ETHICAL ISSUES IN ORGANOIDS RESEARCH FOR USE IN TRANSPLANTATION | Dide de Jongh | ![]() |
![]() |
|||
POS-016 | THE INFLUENCE OF SOCIOECONOMIC FACTORS ON ORGAN DONATION IN IRAN: FINDINGS FROM A SINGLE CENTER STUDY | Sanaz Dehghani | ![]() |
![]() |
|||
POS-017 | QUALITY OF LIFE (QOL) OF RENAL DONORS COMPARED TO FIRST-DEGREE RELATIVES OF HAEMODIALYSIS PATIENTS (THE HIDDEN PATIENT). | Sarah Zaman | ![]() |
![]() |
|||
POS-019 | WHAT ARE THE PSYCHOSOCIAL FACTORS INFLUENCING ACCESS TO KIDNEY TRANSPLANTATION AND TRANSPLANT OUTCOMES FOR CHILDREN? A SYSTEMATIC LITERATURE REVIEW | Ji Soo Kim | ![]() |
![]() |
|||
POS-020 | FROM THE WAITING LIST TO TRANSPLANTATION: HOW IS PATIENTS PERCEPTION OF PROFESSIONALS EVOLVING ALONG THE WAY? | Lia Bellis | ![]() |
![]() |
|||
POS-021 | MEDICATION ADHERENCE IN KIDNEY TRANSPLANT PATIENTS: SINGLE CENTRE COMPARISON BETWEEN PATIENTS 12-18 MONTHS AND AT LEAST 7 YEARS POST-TRANSPLANT | Rosie Heape | ![]() |
![]() |
|||
POS-022 | THE FIRST ITALIAN UTERUS TRANSPLANTATION DURING COVID-19: A PSYCHOLOGICAL AND PSYCHIATRIC EVALUATION IN FIVE CANDIDATES | Maria Luisa Pistorio | ![]() |
![]() |
|||
POS-023 | EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL? | Raquel López-Vilella | ![]() |
![]() |
|||
POS-025 | INVASIVE PULMONARY ASPERGILLOSIS AFTER HEART TRANSPLANTATION | Maria Simonenko | ![]() |
![]() |
|||
POS-026 | ARE HEART TRANSPLANT PATIENTS AT HIGHER RISK FOR MORTALITY FOLLOWING SARS-COV-2 INFECTION? SINGLE CENTRE EXPERIENCE | Sandro Sponga | ![]() |
![]() |
|||
POS-027 | COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL | Víctor Donoso Trenado | ![]() |
![]() |
|||
POS-029 | EARLY EXPERIENCE WITH A NEW STORAGE DEVICE FOR COLD PRESERVATION | Johannes Goekler | ![]() |
![]() |
|||
POS-030 | DISCARDED GRAFTS AFTER CARDIAC EX-VIVO PRESERVATION | Sandro Sponga | ![]() |
![]() |
|||
POS-032 | TEMPORAL RATES OF CELLULAR REJECTION IN THE FIRST TWO YEARS FOLLOWING HEART TRANSPLANTION IN A CONTEMPORARY COHORT. | Paul Callan | ![]() |
![]() |
|||
POS-033 | SAIREITO INDUCED THE SUPPRESSION OF DONOR-SPECIFIC ANTIBODY IN A MURINE CARDIAC ALLOGRAFT TRANSPLANT MODEL | Yasuto Yamamoto | ![]() |
![]() |
|||
POS-035 | FATE OF IMPLANTED AORTIC SCAFFOLDS- ROLE OF EXTRACELLULAR AND IMMUNE PROTEINS | Debashish Banerjee | ![]() |
![]() |
|||
POS-036 | INTESTINAL DONOR CRITERIA: IS THERE ROOM FOR IMPROVEMENT? | Mathias Clarysse | ![]() |
![]() |
|||
POS-037 | INFECTIONS IN SMALL BOWEL AND MULTIVISCERAL TRANSPLANT RECIPIENTS IN A UK CENTRE | Samantha Koh | ![]() |
![]() |
|||
POS-038 | EXTERNAL VALIDATION OF A CLINICO-HISTOPATHOLOGICAL COMPOSITE SCORING SYSTEM TO PREDICT GRAFT FUNCTION IN MARGINAL DONORS. | Mercedes Ruiz Hernández | ![]() |
![]() |
|||
POS-039 | IMPROVING KIDNEY UTILIZATION IN DEVELOPING COUNTRIES | Joel de Andrade | ![]() |
![]() |
|||
POS-040 | IMPACT OF COMBINED CLINICAL AND HISTOLOGICAL ALLOCATION CRITERIA FOR KIDNEY TRANSPLANTS FROM MARGINAL DONORS. | Alessia Terulla | ![]() |
![]() |
|||
POS-041 | URGENCY PRIORITY PATIENTS FOR KIDNEY TRANSPLANTATION, SINGLE CENTER EXPERIENCE | Sahin Eyupoglu | ![]() |
![]() |
|||
POS-042 | MACHINE LEARNING IMPROVES THE ACCURACY OF KIDNEY TRANSPLANT OUTCOME PREDICTIVE MODELS | Laszlo Szabo | ![]() |
![]() |
|||
POS-043 | ESTIMATION OF HEALTH-RELATED QUALITY OF LIFE IN A GREEK COHORT OF KIDNEY TRANSPLANT RECIPIENTS USING THE KIDNEY TRANSPLANT QUESTIONNAIRE 25 (KTQ-25) | Vasileios Koutlas | ![]() |
![]() |
|||
POS-044 | KIDNEY ALLOCATION RULES SIMULATOR | Bruno Lima | ![]() |
![]() |
|||
POS-045 | IMPLEMENTATION OF THE KIDNEY TEAM AT HOME INTERVENTION: EVALUATING GENERALIZABILITY, IMPLEMENTATION PROCESS, AND EFFECTS | Steef Redeker | ![]() |
![]() |
|||
POS-046 | COMPARING SCORES FOR PREDICTING KIDNEY TRANSPLANTATION OUTCOMES | Bruno Lima | ![]() |
![]() |
|||
POS-047 | KIDNEY TRANSPLANTATION FROM ELDERLY DONORS THE EXPERIENCE OF A REFERENCE CENTER IN CROATIA | Stela Zivcic-Cosic | ![]() |
![]() |
|||
POS-048 | MACHINE LEARNING-BASED PREDICTIVE MODEL FOR OUTCOME OF COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS | Ignacio Revuelta | ![]() |
![]() |
|||
POS-049 | 18FFDG PET/CT IMAGING DISPROVES RENAL ALLOGRAFT ACUTE REJECTION IN KIDNEY TRANSPLANT RECIPIENTS WITH ACUTE KIDNEY INJURY: A VALIDATION COHORT | Francois JOURET | ![]() |
![]() |
|||
POS-050 | PREOPERATIVE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) PREDICTS DELAYED GRAFT FUNCTION (DGF) IN RENAL ALLOTRANSPLANTATION. | Vasileios Tatsis | ![]() |
![]() |
|||
POS-052 | URINARY CXCL10 AT 6 MONTHS AFTER KIDNEY TRANSPLANTATION PREDICTS THE HISTOLOGIC FINDINGS OF 1-YEAR SURVEILLANCE BIOPSY | EMILIO RODRIGO CALABIA | ![]() |
![]() |
|||
POS-053 | DICKKOPF 3-PRECISELY REFLECTS SUBSEQUENT KIDNEY ALLOGRAFT DETERIORATION | Antonia Schuster | ![]() |
![]() |
|||
POS-054 | UREMIC TOXIN LEVELS ARE ASSOCIATED WITH GUT MICROBIOME CHANGES IN KIDNEY TRANSPLANT RECIPIENTS | Susana Sampaio Norton | ![]() |
![]() |
|||
POS-055 | IMPACT OF KLOTHO AS A BIOMARKER FOR CANCER SURVEILLANCE IN KIDNEY TRANSPLANT RECIPIENTS | Woo Yeong Park | ![]() |
![]() |
|||
POS-056 | SYSTEMATIC REVIEW OF NON-INVASIVE IMAGING TECHNIQUES USED TO DIRECTLY EVALUATE THE MICROCIRCULATION IN KIDNEY OR LIVER TRANSPLANTATION | Dilan Dabare | ![]() |
![]() |
|||
POS-057 | LOW INVASIVE SPME TISSUE SAMPLING AS A NEW TOOL FOR GRAFT QUALITY ASSESSMENT | Natalia Warmuzinska | ![]() |
![]() |
|||
POS-058 | FUNCTIONAL CATEGORIES DETERMINED BY RNA-SEQ IN URINE OF KIDNEY TRANSPLANT PATIENTS WITH ACUTE REJECTION COMPARED WITH LONG-TERM ALLOGRAFT SURVIVAL | Cristian Alvarez | ![]() |
![]() |
|||
POS-059 | HOW DONOR CYP3A5 EXPRESSION AFFECT TRANSPLANTATION OUTCOMES IN CAUCASIAN POPULATION OF RENAL TRANSPLANT RECIPIENTS | Karola Warzyszynska | ![]() |
![]() |
|||
POS-060 | Glomerular proteome characterization during active antibody-mediated rejection in kidney transplantation highlights interferon-related endothelial stress markers | Bertrand Chauveau | ![]() |
![]() |
|||
POS-061 | EARLY PREDICTION OF RENAL GRAFT FUNCTION: ANALYSIS OF A MULTI-CENTRE, MULTI-LEVEL DATA SET | Arturo Blázquez Navarro | ![]() |
![]() |
|||
POS-063 | DEGRADATION OF KEY CYTOSKELETAL AND GLOMERULAR BASEMENT MEMBRANE PROTEINS ASSOCIATE TO SUBOPTIMAL OUTCOMES IN KIDNEY TRANSPLANTATION | Rebecca Vaughan | ![]() |
![]() |
|||
POS-064 | PARATHYROID HORMONE (PTH) SERUM LEVEL AS PREDICTOR OF OUTCOME IN RENAL TRANSPLANT: A RETROSPECTIVE STUDY | Giuseppe Ietto | ![]() |
![]() |
|||
POS-065 | CALCIFICATION CT ASSESSED CALCIUM SCORING: EFFECTS OF RENAL TRANSPLANT RECIPIENT OUTCOMES | Laura Clementoni | ![]() |
![]() |
|||
POS-066 | LONG TERM OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS WITH CT ASSESSED SARCOPAENIA | Christopher Seet | ![]() |
![]() |
|||
POS-067 | IS ACCOMMODATION AN UNHARMFUL PROCESS IN ABO INCOMPATIBLE KIDNEY TRANSPLANT? | Carlos Couceiro | ![]() |
![]() |
|||
POS-068 | ANTITHROMBOTIC MANAGEMENT IN KIDNEY TRANSPLANTATION AN EUROPEAN SURVEY STUDY | Tamar van den Berg | ![]() |
![]() |
|||
POS-069 | OPTIMIZATION OF ERYTHROPOIETIN STIMULATING AGENTS FOR POST-TRANSPLANT ANEMIA IN KIDNEY RECIPIENTS: PROSPECTIVE RANDOMIZED CONTROLLED TRIAL | Ayman Maher | ![]() |
![]() |
|||
POS-072 | IS SAFE OOCYTE DONATION PREGNANCY AFTER KIDNEY TRANSPLANT? | Alessandro Tomassetti | ![]() |
![]() |
|||
POS-074 | THE CURRENT PRACTICE OF LIVE DONOR NEPHRECTOMY IN TURKEY: RESULTS OF A NATIONWIDE SURVEY | Bakytbek Mankiev | ![]() |
![]() |
|||
POS-075 | DOWN-REGULATION OF INFLAMMATORY SIGNALING PATHWAYS DESPITE UP-REGULATIONOF TOLL-LIKE RECEPTORS; THE EFFECTS OF CORTICOSTEROID THERAPY IN BRAIN-DEAD | Sanaz Dehghani | ![]() |
![]() |
|||
POS-076 | DECISION MAKING ON ORGAN DONATION: THE REASON OF REFUSING FOR DONATION IN NON-DONOR FAMILIES | Sanaz Dehghani | ![]() |
![]() |
|||
POS-077 | KIDNEY RE-TRANSPLANT: SINGLE CENTER EXPERIENCE FROM THE MIDDLE EAST | Osama Gheith | ![]() |
![]() |
|||
POS-078 | EFFICACY AND SAFETY OF MARGINAL GRAFTS FROM EXPANDED CRITERIA DONOR (ECD) AND DONATION AFTER CIRCULATORY DEATH (DCD) IN ERDERLY RECIPIENTS | Ana Dominguez | ![]() |
![]() |
|||
POS-079 | KIDNEY TRANSPLANTATION FROM ELDERLY DONORS: SINGLE-CENTER EXPERIENCE | hakan sozen | ![]() |
![]() |
|||
POS-080 | DECEASED-DONOR INITIATED CHAINS: THREE-YEARS EXPERIENCE OF THE ITALIAN DECK PROGRAM | Lucrezia Furian | ![]() |
![]() |
|||
POS-082 | CHANGES ON MINERAL METABOLISME AFTER LIVING KIDNEY DONATION. ARE THEY IMPORTANT? | NURIA SERRA | ![]() |
![]() |
|||
POS-083 | THE IMPACT OF PRETRANSPLANT RENAL BIOPSY ON THE EVALUATION OF PROSPECTIVE LIVING KIDNEY DONORS | Christina Melexopoulou | ![]() |
![]() |
|||
POS-084 | LONG-TERM OUTCOMES IN OLDER KIDNEY TRANSPLANT RECIPIENTS FROM OLDER DONORS. A PROPENSITY SCORE ANALYSIS | Elena Cuadrado | ![]() |
![]() |
|||
POS-085 | CLINICAL UTILITY AND EVOLUTION OF DONOR SERUM LACTATE DURING NORMOTHERMIC REGIONAL PERFUSION IN UNCONTROLLED DONATION AFTER CIRCULATORY DEATH (UDCD) | David Paredes-Zapata | ![]() |
![]() |
|||
POS-086 | INDIVIDUAL RISK POST-LIVING KIDNEY DONATION: A META-ANALYSIS OF THE EFFECTS OF DONOR DEMOGRAPHIC CHARACTERISTICS | Maria Irene Bellini | ![]() |
![]() |
|||
POS-087 | THE IMPACT ON RECIPIENT DEMOGRAPHICS ON OUTCOMES FROM LIVING DONOR KIDNEYS | Mikhail Nozdrin | ![]() |
![]() |
|||
POS-088 | AGING IN LIVING DONATION. PERIOPERATIVE ANALYSIS | Lucía Peña | ![]() |
![]() |
|||
POS-090 | MIDTERM OUTCOMES OF LIVE KIDNEY TRANSPLANTATION FROM ELDERLY DONORS | Emin Baris Akin | ![]() |
![]() |
|||
POS-091 | ORGAN DONATION IN A DEVELOPING CARIBBEAN COUNTRY: A SINGLE CENTRE EXPERIENCE IN TRINIDAD AND TOBAGO | Hassina Mohammed | ![]() |
![]() |
|||
POS-092 | LONG-TERM OUTCOMES WITH EXPANDED CRITERIA DONORS IN KIDNEY TRANSPLANTATION: 10 YEAR EXPERIENCIA | Andrea Elena García | ![]() |
![]() |
|||
POS-093 | LONG TERM RENAL OUTCOMES IN LIVING DONORS WITH ASYMPTOMATIC NEPHROLITHIASIS | Christopher Seet | ![]() |
![]() |
|||
POS-094 | MEETING PATIENT EXPECTATIONS MATTERS MORE THAN UK KDRI SCORE FOR QUALITY OF LIFE OUTCOMES AFTER KIDNEY TRANSPLANTATION | Hannah Maple | ![]() |
![]() |
|||
POS-095 | ESTRADIOL TREATMENT MODULATES ESTRADIOL RECEPTORS EXPRESSION AND REDUCES RENAL INJURY AFTER BRAIN DEATH IN FEMALE RATS | Cristiano Correia | ![]() |
![]() |
|||
POS-096 | DBD AND DCD SPECIFIC KIDNEY PROTEIN PROFILES ASSOCIATED WITH 12-MONTH POST-TRANSPLANT KIDNEY FUNCTION | Priyanka Joshi | ![]() |
![]() |
|||
POS-097 | EXPERIENCE WITH EXPANDED CRITERIA DONORS IN KIDNEY TRANSPLANTATION IN THE COLOMBIAN CARIBBEAN REGION | Andrea Elena García | ![]() |
![]() |
|||
POS-098 | ANTI-HLA-DP ANTIBODIES POSITIVE - A RETROSPECTIVE REVIEW OF OUTCOMES IN RENAL TRANSPLANTATION- SINGLE CENTRE EXPERIENCE | Oana Piscoran | ![]() |
![]() |
|||
POS-099 | ATHENA IMPACT OF PRIMARY IMMUNOSUPPRESSION ON DEVELOPMENT OF DE NOVO DONOR SPECIFIC ANTIBODIES WITHIN 12 MONTHS POST-KIDNEY TRANSPLANTATION. | Anja Elssser | ![]() |
![]() |
|||
POS-100 | CLUSTERS OF ANTI HLA CLASS II LUMINEX RESPONSES REVEALED BY SIMPLE MACHINE LEARNING ALGORITHMS. IMPLICATIONS FOR DSA STUDIES. | Asimina FYLAKTOU | ![]() |
![]() |
|||
POS-101 | DETECTION AND QUANTIFICATION OF IMMUNOLOGICALLY RELEVANT ALLOANTIBODY-HLA INTERACTIONS USING MICROFLUIDIC ANTIBODY AFFINITY PROFILING | Ashley Priddey | ![]() |
![]() |
|||
POS-102 | HIGH CHOLESTEROL AND AGING NEGATIVELY INFLUENCE RENAL CAPILLARY DENSITY AND TUBULE VILLIN EXPRESSION BY DECREASING CAPILLARY VEGF AND NITRIC OXIDE | B. Handan Ozdemir | ![]() |
![]() |
|||
POS-103 | CLINICAL IMPLICATION OF C1Q DEPOSITION IN KIDNEY TRANSPLANTATION | Eun-Ah Jo | ![]() |
![]() |
|||
POS-104 | SINGLE KIDNEY TRANSPLANT USING ORGANS WITH KARPINSKI/REMUZZI SCORE 6 OR HIGHER: A TABOO TO DISPEL? | Fabio Vistoli | ![]() |
![]() |
|||
POS-105 | RESEARCH BIOPSIES IN KIDNEYS FOR TRANSPLANT: AUDIT TO COMPARE CLINICAL SAFETY WITH TISSUE QUALITY | James Hunter | ![]() |
![]() |
|||
POS-110 | DESENSITIZATION TREATMENT AS AN OPTION FOR HIGH IMMUNOLOGICAL RISK RENAL TRANSPLANT CANDIDATES: SINGLE CENTER EXPERIENCE | Cinthia Baldallo | ![]() |
![]() |
|||
POS-111 | FREQUENCY OF HLA-SPECIFIC IGE ANTIBODIES IN SOLID ORGAN TRANSPLANTATION ANALYSED BY SINGLE-ANTIGEN BEADS-BASED IMMUNOASSAY | Jasmin Mucha | ![]() |
![]() |
|||
POS-112 | PRETRANSPLANT NATURAL KILLER CELLS LEVEL IS INVOLVED IN REJECTION AND OPPORTUNISTIC INFECTION ONSET WITHIN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION | Florence RUNYO | ![]() |
![]() |
|||
POS-114 | DECLINE IN CD4 T CELLS EXPRESSING T CELL IMMUNORECEPTOR WITH IG AND ITIM DOMAINS UNDERLIES DONOR-SPECIFIC HYPORESPONSIVENESS POST TRANSPLANTATION? | Amy van der List | ![]() |
![]() |
|||
POS-115 | THE HLA-DR4-DQ8 PHENOTYPE OF THE RECIPIENT IS ASSOCIATED WITH INCREASED MORTALITY AFTER KIDNEY TRANSPLANTATION | Kit Lund | ![]() |
![]() |
|||
POS-116 | CLINICAL OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS WITH C1Q-BINDING DE NOVO DONOR-SPECIFIC ANTIBODIES: A SINGLE-CENTER EXPERIENCE | Stathis Tsiakas | ![]() |
![]() |
|||
POS-119 | DIMINISHED TREG CELLS IN PERIPHERAL BLOOD IS ASSOCIATED WITH LATE ANTIBODY MEDIATED REJECTION AFTER FIRST YEAR POST KIDNEY TRANSPLANT. | Mariana Seija | ![]() |
![]() |
|||
POS-120 | VALIDATION OF C3, IC3B, C3D, C4D, PROPERDIN C5 AND C5B-9 ASSAYS TO MONITOR COMPLEMENT ACTIVATION IN KIDNEY TRANSPLANT PATIENTS | Rosa Lammerts | ![]() |
![]() |
|||
POS-121 | HUMAN PODOCYTE INJURY OF KIDNEY ALLOGRAFTS IN ANTIBODY-MEDIATED REJECTION | Jie Chen | ![]() |
![]() |
|||
POS-122 | MICROVASCULAR INFLAMMATION IN NO-DSA MEDIATED CHRONIC REJECTION AFTER KIDNEY TRANSPLANTATION | Rostand Emmanuel Nguefouet momo | ![]() |
![]() |
|||
POS-123 | ANGIOTENSIN II TYPE-1 RECEPTOR (AT1R) ANTIBODIES ARE ASSOCIATED WITH INFERIOR RENAL ALLOGRAFT SURVIVAL | Paul Martin | ![]() |
![]() |
|||
POS-124 | THE ROLE OF T LYMPHOCYTES SUBPOPULATIONS IN KIDNEY TRANSPLANTATION | Asimina FYLAKTOU | ![]() |
![]() |
|||
POS-125 | CHANGES OF REGULATORY T LYMPHOCYTES IN KIDNEY TRANSPLANTATION | Efstratios Kasimatis | ![]() |
![]() |
|||
POS-126 | PATTERNS OF IGG REBOUND AFTER IMLIFIDASE TREATMENT | Angela Maldonado | ![]() |
![]() |
|||
POS-127 | MUSEKAL - A MULTI-CENTRE NON-INTERVENTIONAL STUDY TO ASSESS THE TOLERABILITY AND EFFECTIVENESS OF ENVARSUS IN DE NOVO KIDNEY TRANSPLANT PATIENTS | Jarmila Dedochová | ![]() |
![]() |
|||
POS-128 | MUSEKAL - ASSESSING TOLERABILITY AND EFFECTIVENESS OF ENVARSUS IN KIDNEY TRANSPLANT PATIENTS CONVERTED FROM OTHER TACROLIMUS FORMULATIONS | Marcus Seemann | ![]() |
![]() |
|||
POS-129 | EFFECT OF TACROLIMUS EXPOSURE ON EVEROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: A 24-MONTH ANALYSIS FROM TRANSFORM STUDY | Franco Citterio | ![]() |
![]() |
|||
POS-131 | PAIRED STUDY OF KIDNEY DONORS COMPARING TWO FORMULATIONS OF PROLONGED-RELEASE TACROLIMUS (ADVAGRAF VS ENVARSUS). | Verónica López Jiménez | ![]() |
![]() |
|||
POS-132 | SENSITIVITY TO TACROLIMUS NEPHROTOXICITY AND LONG-TERM GRAFT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS | Sabine Vollenbroek | ![]() |
![]() |
|||
POS-133 | COMPARISON OF BASILIXIMAB VS NO INDUCTION ON 24-MONTHS RENAL FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS IN THE TACROLIMUS ERA | Zdenek Lys | ![]() |
![]() |
|||
POS-135 | COMPARISON OF BASILIXIMAB AND R-ATG ON ACUTE REJECTION RISK IN HIGH IMMUNOLOGICAL RISK RENAL TRANSPLANT RECIPIENTS | Hatem Ali | ![]() |
![]() |
|||
POS-136 | ASSOCIATION OF TACROLIMUS TROUGH LEVEL AND DAILY DOSE RATIO WITH OUTCOMES IN A PROSPECTIVE PREVALENT COHORT OF KIDNEY TRANSPLANT RECIPIENTS | Orsolya Cseprekal | ![]() |
![]() |
|||
POS-137 | AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS | Karola Warzyszynska | ![]() |
![]() |
|||
POS-138 | IMPACT OF POLYCLONAL ANTI-T-LYMPHOCYTE GLOBULIN ON THE RECURRENCE OF IGA NEPHROPATHY AFTER KIDNEY TRANSPLANTATION: THE PIRAT STUDY | nicolas maillard | ![]() |
![]() |
|||
POS-139 | THE BURDEN OF GASTRO-INTESTINAL COMPLAINTS IN KIDNEY TRANSPLANT RECIPIENTS USING TACROLIMUS WITH AND WITHOUT MYCOPHENOLATE MOFETIL. | Zainab Al Fatly | ![]() |
![]() |
|||
POS-140 | IMMUNOREGULATION AFTER RITUXIMAB INDUCTION IN BLOOD GROUP INCOMPATIBLE LIVING-DONOR RENAL TRANSPLANTATION 2 YEAR DATA OF A PROSPECTIVE PILOT STUDY | Rolf Weimer | ![]() |
![]() |
|||
POS-141 | LONG- TERM OUTCOMES OF ABO INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION IN GREECE | Christina Melexopoulou | ![]() |
![]() |
|||
POS-142 | COVID-19 AND THE KIDNEY: SINGLE-CENTER EXPERIENCE FROM TURKEY | Sanem Cimen | ![]() |
![]() |
|||
POS-143 | RECURRENT URINARY TRACT INFECTIONS AMONG RENAL TRANSPLANT RECIPIENTS: RISK FACTORS AND OUTCOME WITH DEVELOPING RESISTANCE | osama Gheith | ![]() |
![]() |
|||
POS-144 | CARBAPENEMS PROPHYLAXIS AND EXTENDED-SPECTRUM CEPHALOSPORINS-RESISTANT ENTEROBACTERALES URINARY TRACT INFECTION IN KIDNEY TRANSPLANT RECIPIENTS | Jackrapong Bruminhent | ![]() |
![]() |
|||
POS-145 | EFFECT OF MYCOPHENOLIC ACID AND TACROLIMUS ON THE INCIDENCE OF INFECTIONS AFTER KIDNEY TRANSPLANTATION IN CONTRAST WITH ACUTE KIDNEY REJECTION. | Matej Vnu&269;ák | ![]() |
![]() |
|||
POS-146 | TUBERCULOSIS IN KIDNEY TRANSPLANT RECIPIENTS IN A UNIVERSAL ISONIAZID PROPHYLAXIS SETTING | Jackrapong Bruminhent | ![]() |
![]() |
|||
POS-147 | COVID-19 POSITIVE KIDNEY TRANSPLANT RECIPIENTS BEHAVE DIFFERENTLY DURING THE UNREMITTING STAGE WITH OPTIMIZED ANTICOAGULATION AND IMMUNOSUPPRESSION | osama Gheith | ![]() |
![]() |
|||
POS-148 | ACUTE KIDNEY INJURY AMONG COVID-19 POSITIVE PATIENTS IS ASSOCIATED WITH HIGHER MORTALITY: SINGLE CENTER EXPERIENCE. | osama Gheith | ![]() |
![]() |
|||
POS-149 | CRITICALLY ILL COVID-19 POSITIVE KIDNEY TRANSPLANT RECIPIENTS BEHAVE DIFFERENTLY COMPARED TO NON-TRANSPLANT PATIENTS: SINGLE CENTER EXPERIENCE. | Ayman Maher | ![]() |
![]() |
|||
POS-151 | GENDER AND AGE DISPARITY IN INFECTIOUS COMPLICATIONS AFTER KIDNEY TRANSPLANTATION. | Matej Vnu&269;ák | ![]() |
![]() |
|||
POS-154 | MAY ROUTINE BIOMARKERS FOR THE SEVERITY OF COVID-19 PNEUMONIA DIFFERENCE SARS-COV-2 INFECTION TO OTHERS INFECTIONS IN KIDNEY TRANSPLANT RECIPIENTS? | María Molina | ![]() |
![]() |
|||
POS-155 | NOVEL AGENTS FOR ERADICATING HEPATITIS C VIRUS IN RENAL TRANSPLANT RECIPIENTS | Rosita Greco | ![]() |
![]() |
|||
POS-156 | RISK FACTORS FOR MORTALITY IN KIDNEY TRANSPLANT PATIENTS INFECTED BY SARS-COV-2 IN SOUTH OF SPAIN | Verónica López Jiménez | ![]() |
![]() |
|||
POS-157 | CLINICAL PREDICTORS OF COVID-19 DISEASE SEVERITY IN KIDNEY TRANSPLANT RECIPIENTS | Pedro Lisboa Gonalves | ![]() |
![]() |
|||
POS-158 | WILLINGNESS OF KIDNEY TRANSPLANT RECIPIENTS TO RECEIVE COVID-19 VACCINE | Ieva Ziedina | ![]() |
![]() |
|||
POS-160 | REMDESIVIR IS USEFUL AND SAFE IN KIDNEY TRANSPLANTAT PATIENTS WITH SARS-CoV PNEUMONIAE. | Judit Cacho | ![]() |
![]() |
|||
POS-161 | EXTERNAL URETERIC STENT VS. INTERNAL DOUBLE J STENT IN RENAL TRANSPLANTATION: OCCURRENCE OF URINARY TRACT INFECTIONS AND UROLOGIC COMPLICATIONS | Margriet Hazenberg | ![]() |
![]() |
|||
POS-163 | KIDNEY TRANSPLANTATION ACTIVITY DURING COVID PANDEMIC - A SINGLE CENTER EXPERIENCE | AHMAD MIRZA | ![]() |
![]() |
|||
POS-165 | RISK FACTORS FOR HOSPITAL ADMISSIONS AFTER MONOCLONAL ANTIBODIES FOR COVID-19 INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS | Lana Hasan | ![]() |
![]() |
|||
POS-166 | TRANSPLANT RELATED RISK FACTORS ANALYSIS OF MORTALITY IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19 - A SINGLE CENTER-BASED RETROSPECTIVE STUDY | Dr Ashish Sharma | ![]() |
![]() |
|||
POS-167 | THE SERUM LEVELS OF ANTI-SARS-COV-2 ANTIBODIES REMAIN DETECTABLE AT 9 MONTHS POST COVID-19 IN SYSTEMATICALLY SCREENED KIDNEY TRANSPLANT RECIPIENTS | Louis FIRKET | ![]() |
![]() |
|||
POS-169 | COVID-19 infection rates/outcomes in clinically extremely vulnerable renal replacement therapy patients admitted for procedures during the pandemic | Connie Rose Gabor | ![]() |
![]() |
|||
POS-172 | PREDICTIVE FACTORS AND OUTCOMES OF URINARY TRACT INFECTIONS AFTER KIDNEY TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY | Tlili Syrine | ![]() |
![]() |
|||
POS-174 | URINARY TRACT INFECTIONS AND LONG TERM OUTCOMES AFTER PEDIATRIC RENAL TRANSPLANTATION | Aydincan Akdur | ![]() |
![]() |
|||
POS-175 | ROUTINE TRANSPLANT URETERIC STENT CULTURE - UTILITY IN IDENTIFYING PATIENTS AT HIGHER RISK OF URINARY TRACT INFECTION | Bynvant Sandhu | ![]() |
![]() |
|||
POS-177 | SARS-COV-2 IGG SEROPREVALENCE AND FACTORS AFFECTING ITS LEVELS IN KIDNEY TRANSPLANT RECIPIENTS DURING SECOND PEAK OF COVID-19 PANDEMIC | Maria Magicova | ![]() |
![]() |
|||
POS-178 | THE BITTER SWEET ENEMY OF RENAL TRANSPLANT RECIPIENTSA DEMI DECADE EXPERIENCE OF POST RENAL TRANSPLANT GRAFT OUTCOMES IN DIABETIC KIDNEY DISEASE | Kevin T John Keeppallil | ![]() |
![]() |
|||
POS-179 | NOVEL CORONAVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS (A SINGLE-CENTER EXPERIENCE) | Elena Semenova | ![]() |
![]() |
|||
POS-180 | INFLUENCE OF VITAMIN D STATUS ON THE PROGNOSIS OF COVID 19 IN PATIENTS WITH KIDNEY TRANSPLANT | Jessica Marlia Ugalde Altamirano | ![]() |
![]() |
|||
POS-181 | EFFECTS OF OXYGEN DURING HYPOTHERMIC MACHINE PERFUSION IN AN EXPERIMENTAL PORCINE MODEL OF KIDNEY DONATION AFTER CARDIAC DEATH. ADDED CONTROVERSIES | Victoria Gomez | ![]() |
![]() |
|||
POS-182 | PREDICTORS OF DEVELOPMENT AND DURATION OF DELAYED GRAFT FUNCTION (DGF) IN MARGINAL KIDNEYS WITH HYPOTHERMIC PULSATILE MACHINE PERFUSION (HPMP) | Ana Dominguez | ![]() |
![]() |
|||
POS-183 | DELAYED GRAFT FUNCTION; DOES IT REALLY BURDEN FOR DECEASED DONOR KIDNEY TRANSPLANTS? | Hakan Sozen | ![]() |
![]() |
|||
POS-184 | HYPOTHERMIC MACHINE PERFUSION CAN BE SAFELY USED TO PROLONG COLD ISCHEMIA TIME IN DECEASED DONOR KIDNEY TRANSPLANTATION | Riccardo Pravisani | ![]() |
![]() |
|||
POS-185 | IMPACT ON KIDNEY TRANSPLANTATION OF THE PERCENTAGE OF T LYMPHOCYTES ISOLATED FROM HEPATIC PERFUSATE OF MULTI-ORGAN DECEASED BRAIN DONORS. | Duilio Pagano | ![]() |
![]() |
|||
POS-186 | DOES OXYGENATION AT PO2 21 DURING HYPOTHERMIC MACHINE PERFUSION (HMP) IMPROVE THE CLINICAL OUTCOME OF DECEASED DONOR KIDNEY TRANSPLANTATION? | Riccardo Pravisani | ![]() |
![]() |
|||
POS-187 | FROSTBITE LESIONS OF KIDNEYS RETRIEVED FROM DECEASED DONORS AND FAILED USE: A NATIONAL APPROACH BY THE ITALIAN NATIONAL TRANSPLANT CENTER | Raffaele Donadio | ![]() |
![]() |
|||
POS-188 | DUAL AND OPPOSITE COSTIMULATORY TARGETING WITH A NOVEL HUMAN RECOMBINANT PROTEIN PREVENTS RENAL WARM IRI AND ALLOGRAFT REJECTION IN MURINE MODELS | Jordi Guiteras | ![]() |
![]() |
|||
POS-189 | FUNCTIONAL MRI ASSESSMENT DURING EX VIVO NORMOTHERMIC PERFUSION: THE FIRST EXPERIENCE WITH DISCARDED HUMAN KIDNEYS | Tim Hamelink | ![]() |
![]() |
|||
POS-190 | COMPARISON BETWEEN KIDNEY TRANSPLANTATION AFTER CIRCULATORY DEATH AND AFTER BRAIN DEATH:A MONOCENTRIC RETROSPECTIVE STUDY AFTER TWO YEARS OF FOLLOW-UP | Laura Tonelli | ![]() |
![]() |
|||
POS-191 | Validation of the preclinical models for renal ischemia reperfusion injury: a systematic review | Lente Lerink | ![]() |
![]() |
|||
POS-192 | THE EFFECT OF A KETOGENIC DIET ON MITOCHONDRIAL FUNCTION IN PORCINE PRECISION-CUT KIDNEY SLICES | Lydia Annick Van Furth | ![]() |
![]() |
|||
POS-193 | EVALUATION OF SEX DIFFERENCES IN ACUTE KIDNEY INJURY AFTER BD USING AN ISOLATED PERFUSED RAT KIDNEY MODEL | Roberto Armstrong-Jr | ![]() |
![]() |
|||
POS-194 | CONTROLLED OXYGENATED REWARMING PROTECTS MITOCHONDRIAL FUNCTION IN DCD PORCINE RENAL GRAFTS. | Hristo Zlatev | ![]() |
![]() |
|||
POS-195 | INFRARED THERMAL IMAGING: A NON-INVASIVE, REAL-TIME, BIOMARKER FOR PREDICTING EARLY GRAFT FUNCTION IN KIDNEY TRANSPLANTATION | Dilan Dabare | ![]() |
![]() |
|||
POS-196 | COMPARISON OF EARLY POSTTRANSPLANT OUTCOMES IN KIDNEYS PRESERVED BY HYPOTHERMIA MACHINE PERFUSION AND STATIC COLD STORAGE | Janis Jushinskis | ![]() |
![]() |
|||
POS-197 | IS VITAMIN D DEFICIENCY RELATED TO REJECTION AND CHRONIC ALLOGRAFT NEPHROPATHY? | Sanem Cimen | ![]() |
![]() |
|||
POS-198 | IMPACT OF STRUCTURED DIABETES EDUCATION ON SELF-CARE DIABETES MANAGEMENT OF KIDNEY TRANSPLANTS WITH POST-TRANSPLANT DIABETES: KUWAIT EXPERIENCE | osama Gheith | ![]() |
![]() |
|||
POS-199 | T- CELLS COMMANDS CHIEF ORCHESTRAS FOR POST-TRANSPLANT DIABETES | osama Gheith | ![]() |
![]() |
|||
POS-200 | EFFECT OF PHYSICAL ACTIVITY AND LIFESTYLE CHANGES ON INSULIN RESISTANCE IN PATIENTS AFTER KIDNEY TRANSPLANTATION | Karol Gra&328;ák | ![]() |
![]() |
|||
POS-201 | EFFECT OF STRUCTURED DIABETES EDUCATION ON DIABETIC ANGIOPATHIES AMONG KIDNEY TRANSPLANTS WITH POST-TRANSPLANT DIABETES: KUWAIT EXPERIENCE | osama Gheith | ![]() |
![]() |
|||
POS-202 | FLUDROCORTISONE AMONG RENAL TRANSPLANT RECIPIENTS WITH PERSISTENT HYPERKALEMIA: SINGLE CENTER EXPERIENCE. | Mohamed Zahab | ![]() |
![]() |
|||
POS-203 | DETERMINANTS OF SECONDARY HYPERPARATHYROIDISM RESOLUTION AFTER KIDNEY TRANSPLANTATION. | Maria Smyrli | ![]() |
![]() |
|||
POS-204 | THYROTOXICOSIS AFTER KIDNEY TRANSPLANT: AN EARLY POST-OPERATIVE COMPLICATION | Francesca Ferrara | ![]() |
![]() |
|||
POS-206 | SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS (SGLT2I) SHORT-TERM OUTCOME IN DIABETIC KIDNEY TRANSPLANT RECIPIENTS | Jude Yagan | ![]() |
![]() |
|||
POS-208 | HIGHER OBESITY CLASSES (II/III) ARE ASSOCIATED WITH INCREASED PERI-OPERATIVE SURGICAL COMPLICATIONS IN KIDNEY TRANSPLANT RECIPIENTS. | Chukwugozie Chukwuenweniwe | ![]() |
![]() |
|||
POS-209 | FUNCTIONAL OUTCOMES OF END-ISCHEMIC HYPOTHERMIC MACHINE PERFUSION. | Mercedes Ruiz Hernández | ![]() |
![]() |
|||
POS-210 | DELAYED MACHINE-PERFUSED KIDNEY IMPLANTATION IN COMBINED LIVER AND KIDNEY TRANSPLANT: EARLY SINGLE CENTER EXPERIENCE. | Andrea Lauterio | ![]() |
![]() |
|||
POS-213 | CLINICAL EFFICACY OF DUAL-KIDNEY TRANSPLANTATION FROM PEDIATRIC DONORS TO ADULT RECIPIENTS | Mingchuan Huang | ![]() |
![]() |
|||
POS-214 | ASSESSMENT OF CYSTINOSIS IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS: CASE CONTROL STUDY FROM KUWAIT | osama Gheith | ![]() |
![]() |
|||
POS-215 | LOVER URINARY TRACT DYSFUNCTION AND TRANSPLANTATION OUTCOME:A SINGLE CENTER EXPERIENCE | hakan sozen | ![]() |
![]() |
|||
POS-217 | A THIRD OF CHILDREN AND THEIR FAMILIES HAD SIGNIFICANT FEAR ABOUT RENAL TRANSPLANTATION DURING THE COVID PANDEMIC | Alicia Paessler | ![]() |
![]() |
|||
POS-218 | KIDNEY TRANSPLANTED PATIENTS FROM PEDIATRIC TO ADULT TRANSPLANT CENTRE: TRANSITION DIFFICULTIES AND MANAGEMENT | Francesca Tinti | ![]() |
![]() |
|||
POS-219 | COMPLEX BENCH SURGERY DID NOT INCREASE THE RISK OF VASCULAR COMPLICATIONS AFTER PEDIATRIC KIDNEY TRANSPLANTATION | Filippo Ghidini | ![]() |
![]() |
|||
POS-220 | UTILISING THE HEMIAZYGOS VENOUS SYSTEM IN LIVING AND DECEASED DONOR PAEDIATRIC KIDNEY TRANSPLANTATION | Sergio Assia-Zamora | ![]() |
![]() |
|||
POS-224 | RENAL TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-INFECTED PATIENTS | Marta Santiago González | ![]() |
![]() |
|||
POS-225 | KIDNEY TRANSPLANTATION DURING THE COVID-19 PANDEMIC PERIOD: A SINGLE CENTER EXPERIENCE | Emre KARAKAYA | ![]() |
![]() |
|||
POS-227 | INFLUENCE OF DIFFERENT TRENDS ON RESULTS OF KIDNEY TRANSPLANTS AT A SINGLE CENTER | Victor Denisov | ![]() |
![]() |
|||
POS-228 | CHILDBIRTH AFTER KIDNEY TRANSPLANTATION COMPARING DIFFERENT DECADES IN THE HISTORY OF OUR UNIT. BUDAPEST EXPERIENCE | Anna Zsófia Meltzer | ![]() |
![]() |
|||
POS-229 | DIGITAL MATURITY OF UNITED KINGDOM RENAL TRANSPLANT CENTRES | Videha Sharma | ![]() |
![]() |
|||
POS-230 | EXERCISE INTERVENTIONS IN RENAL TRANSPLANT PATIENTS: A FULL REVIEW | Ilias Marios Oikonomou | ![]() |
![]() |
|||
POS-231 | PROTECTING SURGICAL PATIENTS DURING THE COVID-19 PANDEMIC; ADVANTAGES FROM THE ESTABLISHMENT OF A REGIONAL CLINICAL NETWORK | Richard Dumbill | ![]() |
![]() |
|||
POS-232 | A SINGLE-CENTER ANALYSIS OF UNPLANNED HOSPITAL READMISSIONS AFTER KIDNEY TRANSPLANTATION: INCIDENCE, CAUSES AND RISK FACTORS | Tlili Syrine | ![]() |
![]() |
|||
POS-233 | EMOTIONAL INTELLIGENCE, PSYCHOPATHOLOGY, AND THERAPEUTIC ADHERENCE IN KIDNEY TRANSPLANTATION DURING COVID-19 | Maria Luisa Pistorio | ![]() |
![]() |
|||
POS-234 | Timing and duration of pre-transplant screening: is there room for improvement? | Marie Dirix | ![]() |
![]() |
|||
POS-235 | COUNSELLING ON CONCEIVING: CONSIDERATIONS OF PROFESSIONALS IN TRANSPLANTATION | Marleen van Buren | ![]() |
![]() |
|||
POS-236 | ENHANCED RECOVERY AFTER SURGERY AFTER KIDNEY TRANSPLANTATION: FEASIBILITY AND PREDICTIVE FACTORS IN THE ERA OF EXTENDED CRITERIA DONORS. | Marco Pellicciaro | ![]() |
![]() |
|||
POS-237 | SUBJECTIVE CHANGES IN LOWER URINARY TRACT SYMPTOMS AFTER RENAL TRANSPLANTATION | Joanna Chorbi&324;ska | ![]() |
![]() |
|||
POS-238 | ADHERENCE AND PATIENTS ATTITUDE TO IMMUNOSUPPRESSIVE THERAPY AFTER KIDNEY TRANSPLANTATION | Fernanda Ortiz | ![]() |
![]() |
|||
POS-239 | ESTABLISHING A KIDNEY- PANCREAS TRANSPLANTATION CENTER IN SRI-LANKA- SUPPORTED BY THE ISN-TTS SISTER TRANSPLANT PROGRAM | Entela Kondi | ![]() |
![]() |
|||
POS-240 | CONSOLIDATION OF KIDNEY TRANSPLANT PROGRAM IN THE REGION OF MINDANAO (PHILIPPINES) UNDER ISN SISTER RENAL CENTER (SRC) PROGRAM. 5 YEARS EXPERIENCE. | Chlo Ballesté | ![]() |
![]() |
|||
POS-241 | DONOR BLOOD TYPE O IS A RISK FACTOR FOR BK POLYOMA VIREMIA IN KIDNEY TRANSPLANT RECIPIENTS | Ruth Rahamimov | ![]() |
![]() |
|||
POS-242 | TRANSPLANT IN TIMES OF A SARS-COV2 PANDEMIC, EXPERIENCE IN REFERENCE CENTER PUBLIC HOSPITAL IN MEXICO | Luis Garcia Covarrubias | ![]() |
![]() |
|||
POS-247 | RAPID VS. LATE RE-TRANSPLANTATION FOR EARLY KIDNEY GRAFT LOSS | Diana Rodríguez Espinosa | ![]() |
![]() |
|||
POS-248 | GENE EXPRESSION ANALYSIS USING QRT-PCR IN THE DIAGNOSIS OF ANTIBODY-MEDIATED REJECTION IN RENAL TRANSPLANT BIOPSIES | Frederic Toulza | ![]() |
![]() |
|||
POS-249 | IMPACT OF DE NOVO DONOR SPECIFIC ANTIBODY ACCORDING TO THE TRANSPLANT TYPE IN KIDNEY TRANSPLANTATION | Woo Yeong Park | ![]() |
![]() |
|||
POS-250 | PRE-TRANSPLANT DONOR-REACTIVE IL-21 PRODUCING T CELLS CAN HELP PREDICT PATIENTS AT RISK FOR ACUTE REJECTION | Aleixandra Mendoza Rojas | ![]() |
![]() |
|||
POS-251 | TOCILIZUMAB IN THE TREATMENT OF ACTIVE CHRONIC HUMORAL REJECTION RESISTANT TO STANDARD THERAPY | Betty Chamoun Huacón | ![]() |
![]() |
|||
POS-252 | CD68 URINARY CELLS AS A SURROGATE MARKER OF REJECTION IN KIDNEY TRANSPLANTATION AND CLINICAL-PATHOLOGICAL CORRELATION | Francesca Gervasi | ![]() |
![]() |
|||
POS-253 | BIOPSY FINDINGS AFTER DETECTION OF DE NOVO DONOR-SPECIFIC ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS - A SINGLE CENTER EXPERIENCE | Christoph Waldecker | ![]() |
![]() |
|||
POS-254 | TOCILIZUMAB TREATMENT IN DSA POSITIVE ANTIBODY MEDIATED REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS | Orsolya Cseprekal | ![]() |
![]() |
|||
POS-255 | CD56BRIGHT CD16DIM NK CELLS PRESENT INCREASED PHENOTYPIC ACTIVATION AND PRO-INFLAMMATORY CYTOKINE SECRETION DURING KIDNEY REJECTION | Elodie Bailly | ![]() |
![]() |
|||
POS-259 | ROBOTIC LIVING-DONOR KIDNEY HARVESTING. DOES LONGER WARM ISCHEMIC TIME AFFECT THE TRANSPLANT OUTCOME? | Alessandro Giacomoni | ![]() |
![]() |
|||
POS-260 | ANALYSIS OF RISK FACTORS AND LONG-TERM OUTCOMES IN KIDNEY TRANSPLANT PATIENTS WITH IDENTIFIED LYMPHOCELES | Tlili Syrine | ![]() |
![]() |
|||
POS-261 | RETROSPECTIVE AND DESCRIPTIVE STUDY OF INCISIONAL HERNIA PREVALENCE ON KIDNEY TRANSPLANT AND RISK FACTORS ASSOCIATED. | Jose Antonio López Plaza | ![]() |
![]() |
|||
POS-263 | ROUTINE ULTRASOUND FOLLOWING TRANSPLANT URETERIC STENT REMOVAL DOES IT ALTER PATIENT MANAGEMENT? | Bynvant Sandhu | ![]() |
![]() |
|||
POS-264 | IMPACT OF PREOPERATIVE ABDOMINAL ADIPOSE TISSUE ON SURGICAL COMPLICATIONS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION | Yang Xu | ![]() |
![]() |
|||
POS-265 | PRETRANSPLANT MANAGEMENT OF PATIENTS WITH POLYCYSTIC KIDNEY DISEASE | Vasilii Dayneko | ![]() |
![]() |
|||
POS-266 | USE OF BOVINE PERICARDIAL PATCH IN LIVING AND DECEASED DONOR KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE ON 14 ARTERIAL RECONSTRUCTIONS. | Maurizio Iaria | ![]() |
![]() |
|||
POS-269 | INNATE IMMUNE INTERACTION WITH REENDOTHELIZED VEIN SCAFFOLDS | Yvette Den Hartog | ![]() |
![]() |
|||
POS-271 | MALIGNANCY AFTER RENAL TRANSPLANTATION, AN ENTITY THAT MUST KEEP EXPERTS ALERT. | Konstantinos Botsakis | ![]() |
![]() |
|||
POS-272 | MALIGNANCY AFTER KIDNEY TRANSPLANTATION - A SINGLE CENTRE OBSERVATIONAL STUDY | Luisa Costa | ![]() |
![]() |
|||
POS-273 | ASSOCIATION OF SKIN CANCER WITH THE USE OF MYCOPHENOLATE OR AZATHIOPRINE IN RENAL TRANSPLANT | Gauri Shankar Jagadesh | ![]() |
![]() |
|||
POS-274 | DONOR-TRANSMITTED MELANOMA THE NEED FOR CONTINUOUSLY UPDATED GUIDELINES | Christopher Seet | ![]() |
![]() |
|||
POS-275 | IMBALANCE OF RESOURCES, AN HYPOTHESIS FOR A NEW WAY OF ALLOCATING LIVERS NOT USED IN THE DONATION REGION | Silvia Trapani | ![]() |
![]() |
|||
POS-276 | EVOLUTION OF WAITING LIST FOR LIVER TRANSPLANTATION OVER 20 YEARS IN ONE SINGLE CENTRE IN ROMANIA | Speranta Iacob | ![]() |
![]() |
|||
POS-277 | LIVER TRANSPLANTATION FOR T2 HEPATOCELLULAR CARCINOMA IN THE COVID-19 PANDEMIC: A NEW MODEL BALANCING INDIVIDUAL BENEFIT AGAINST HEALTHCARE RESOURCES | Alessandro Vitale | ![]() |
![]() |
|||
POS-278 | LIVER TRANSPLANTATION IN THE ELDERLY: PROPOSAL FOR AN INNOVATIVE PATIENT SELECTION PROTOCOL | Alessandro Furlanetto | ![]() |
![]() |
|||
POS-279 | MODIFICATION OF DROP-OUT RATES AFTER FOUR YEARS FROM ITALIAN SCORE FOR ORGAN ALLOCATION INTRODUCTION AT A SINGLE CENTRE: A COMPETING RISK ANALYSIS. | Enrico Prosperi | ![]() |
![]() |
|||
POS-281 | EVALUATING THE EFFICIENCY OF A NATIONAL ADAPTIVE ALLOCATION SCORING SYSTEM FOR LIVER TRANSPLANTATION: A PRELIMINARY BENCHMARKING ANALYSIS. | Silvia Trapani | ![]() |
![]() |
|||
POS-282 | LIVER TRANSPLANTATION IN PATIENTS 70 YEARS RESULTS IN GOOD LONG-TERM OUTCOME - A EUROTRANSPLANT REGISTRY ANALYSIS | Alexander Tyercha | ![]() |
![]() |
|||
POS-284 | PROTEOMICS IN LIVER TRANSPLANTATION: BIOMARKERS BEYOND GENOMICS. A SYSTEMATIC REVIEW. | Victor López López | ![]() |
![]() |
|||
POS-285 | C-REACTIVE PROTEIN AND UREA BLOOD LEVELS DISTINGUISH PRIMARY NON-FUNCTION FROM EARLY ALLOGRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION | James Halle-Smith | ![]() |
![]() |
|||
POS-286 | PROGNOSTIC VALUE OF PIVKA-II LABELLING IN LESIONS OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION | Suzanne Chabert | ![]() |
![]() |
|||
POS-289 | DONOR CHARACTERISTICS CAN BE PREDICTIVE OF THE HEPATIC ARTERY THROMBOSIS IN LIVER TRANSPLANTATION | Marco Maria Pascale | ![]() |
![]() |
|||
POS-290 | LIVER TRANSPLANTATION AND ISCHEMIC CARDIOPATHY: OUTCOMES OF PRE-TRANSPLANT CORONARY STENTING | Paolo Magistri | ![]() |
![]() |
|||
POS-291 | CLINICAL APPLICATION OF EXTRACORPOREAL PHOTOPHERESIS AS AN ALTERNATIVE STRATEGY IN POSTTRANSPLANT IMMUNOSUPPRESSIVE THERAPY | Sergey Korotkov | ![]() |
![]() |
|||
POS-292 | MULTICENTRIC DONOR SURVEY 20 YEARS AFTER DONOR HEPATECTOMY | Oya M. Andacoglu | ![]() |
![]() |
|||
POS-293 | SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA | Margarita Fernández de la Varga | ![]() |
![]() |
|||
POS-294 | COMPARISON OF ANTE-MORTEM VS POST-MORTEM CANNULATION IN LIVER DONATION AFTER CIRCULATORY DETERMINATION OF DEATH | Gabriel Moreno-Gonzalez | ![]() |
![]() |
|||
POS-295 | PROSPECTIVE HISTOLOGICAL ANALYSIS OF DONOR AND RECIPIENTS HEPATIC ARTERY IN LIVER TRANSPLANTATION. | Ivan Vella | ![]() |
![]() |
|||
POS-296 | ERG IN SITU EXPRESSION AS A MARKER OF ENDOTHELIAL STRESS IN EXTENDED CRITERIA DONORS BEFORE AND AFTER GRAFT REPERFUSION. | Francesco Vasuri | ![]() |
![]() |
|||
POS-297 | EXTRAHEPATIC MANIFESTATIONS IN PATIENTS WITH LIVER TRANSPLANTATION DUE TO AUTOIMMUNE LIVER DISEASE | Gema Vázquez Contreras | ![]() |
![]() |
|||
POS-298 | PERIPHERAL BLOOD TREG:TH17 RATIO IN LIVER TRANSPLANT RECIPIENTS WITH ACUTE REJECTION: ASSESSMENT UTILIZING MAXPAR IMMUNE PROFILING ASSAY. | Angus Hann | ![]() |
![]() |
|||
POS-299 | MUSEKAL - A MULTI-CENTRE NON-INTERVENTIONAL STUDY TO ASSESS THE TOLERABILITY AND EFFECTIVENESS OF ENVARSUS IN DE NOVO LIVER TRANSPLANT PATIENTS | Gabriela Berlakovich | ![]() |
![]() |
|||
POS-300 | MELTDOSE TECHNOLOGY PROLONGED RELEASE TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: MID-TERM EVALUATION OF THE SAFETY AND EFFICACY | Fabio Melandro | ![]() |
![]() |
|||
POS-301 | DIFFERENT EFFECTS OF TACROLIMUS, MYCOPHENOLATE MOFETIL AND RAPAMYCIN ON APOPTOSIS IN HUMAN HEPATOCYTES CULTURES | Razvan Iacob | ![]() |
![]() |
|||
POS-302 | IMPACT OF SARS-COV-2 PANDEMIC ON TRANSPLANTATION ACTIVITY IN ITALY: THE REPORTING AT THE END OF THE YEAR | Silvia Trapani | ![]() |
![]() |
|||
POS-303 | PNEUMOCYSTIS JIROVECII PNEUMONIA IN LIVER TRANSPLANT RECIPIENTS IN AN ERA OF ROUTINE PROPHYLAXIS | Philip Andreasen | ![]() |
![]() |
|||
POS-305 | TENOFOVIR ALAFENAMIDE FOR HEPATITIS B VIRUS PROPHYLAXIS POST-LIVER TRANSPLANTATION: A REAL-WORLD STUDY IN PATIENTS WITH CHRONIC KIDNEY DISEASE | Emmanouil Sinakos | ![]() |
![]() |
|||
POS-308 | LIVER TRANSPLANTATION RESULTS IN THE ERA OF MODERN ANTIVIRAL THERAPY OF HEPATITIS C | Kseniia Kokina | ![]() |
![]() |
|||
POS-309 | INFLUENZA IN LIVER TRANSPLANT RECIPIENTS: INCIDENCE AND OUTCOMES | Nicoline Stender Arentoft | ![]() |
![]() |
|||
POS-310 | EARLY LIVER GRAFT DYSFUNCTION IS A RISK FACTOR FOR A RELAPAROTOMY FOR HEMOPERITONEUM (WITH NO APPARENT SOURCE OF BLEEDING). | Denis Efimov | ![]() |
![]() |
|||
POS-312 | LIVER GRAFTS FROM CONTROLLED AND UNCONTROLLED DONATION AFTER CIRCULATORY DEATH IN ITALY: PRESERVATION PROTOCOL AND RESULTS | Riccardo De Carlis | ![]() |
![]() |
|||
POS-315 | PERIOPERATIVE RISK FACTORS OF ACUTE KIDNEY INJURY POST LIVER TRANSPLANTATION: A MONOCENTRIC RETROSPECTIVE COHORT STUDY OF 260 PATIENTS | Clarisse Malisoux | ![]() |
![]() |
|||
POS-316 | EX-VIVO LIVER SPLITTING DURING HYPOTHERMIC OXYGENATED PERFUSION : A NOVEL PROCEDURE TO OPTIMIZE GRAFT PRESERVATION IN SPLIT LIVER TRANSPLANTATION | Guillaume Rossignol | ![]() |
![]() |
|||
POS-318 | IL-6 LEVEL AFTER LIVER TRANSPLANTATION IN PATIENTS DEVELOPING ACUTE KIDNEY INJURY | Francesca Tinti | ![]() |
![]() |
|||
POS-319 | PROTECTION OF MITOCHONDRIAL MACHINERY IN HYPOTHERMIC STATIC ISCHEMIA PRESERVATION: A ROLE FOR IGL2 SOLUTION | ARNAU PANISELLO ROSELLO | ![]() |
![]() |
|||
POS-320 | IGL2: A SOLUTION FOR LIVER HYPOTHERMIC OXYGENATED PERFUSION (HOPE) STRATEGIES. | ARNAU PANISELLO ROSELLO | ![]() |
![]() |
|||
POS-321 | THE RELEASE OF EXTRACELLULAR VESICLES DURING LIVER NORMOTHERMIC MACHINE PERFUSION: A POTENTIAL SOURCE OF VIABILITY MARKERS | Nicholas Gilbo | ![]() |
![]() |
|||
POS-322 | CALL FOR AN INTERNATIONAL STUDY TO IDENTIFY TRAJECTORIES TO EARLY ALLOGRAFT FAILURE AND ASSESS HOW EARLY RETRANSPLANT MAY IMPACT ON PATIENT SURVIVAL | giovanni moschetta | ![]() |
![]() |
|||
POS-323 | PROLONGED COLD STORAGE PRIOR TO NORMOTHERMIC MACHINE PERFUSION ALTERS THE MOLECULAR PROFILE OF DONOR LIVERS: INSIGHTS FROM BACK TO BASE LIVER NMP. | Fungai Dengu | ![]() |
![]() |
|||
POS-324 | INTRODUCING NORMOTHERMIC MACHINE PERFUSION (ORGANOX) INTO CLINICAL PRACTICE THE EDINBURGH EXPERIENCE | Chris Johnston | ![]() |
![]() |
|||
POS-326 | EX SITU ISCHAEMIA REPERFUSION MOBILISES PASSENGER LEUKOCYTES INTO THE CIRCUIT DURING LIVER NORMOTHERMIC MACHINE PERFUSION. | Fungai Dengu | ![]() |
![]() |
|||
POS-327 | NO DIFFERENCE IN OUTCOMES OF LIVER TRANSPLANTATION USING ELDERLY DONOR GRAFTS VERSUS YOUNG DONOR GRAFTS IN THE SETTING OF SHORT COLD ISCHEMIA TIMES | Miran Bezjak | ![]() |
![]() |
|||
POS-328 | POST-TRANSPLANT DIABETES PREDICTS SOLID EXTRA-HEPATIC NON-SKIN CANCER IN LIVER TRANSPLANT RECIPIENTS: A LONG-TERM FOLLOW-UP STUDY | Paolo Magistri | ![]() |
![]() |
|||
POS-329 | DIABETES MELLITUS AND PRE-DIABETES IN PRE-LIVER TRANSPLANT PATIENTS: PREVALENCE AND CHARACTERISTICS | Lorella Marselli | ![]() |
![]() |
|||
POS-330 | TACROLIMUS BLOOD-BILE RATIO FOR THE EARLY DETECTION OF THE REJECTION GRAFT INJURY AFTER LIVER TRANSPLANTATION | Marco Maria Pascale | ![]() |
![]() |
|||
POS-331 | IN-HOSPITAL GLYCEMIC CONTROL AFTER LIVER TRANSPLANTATION: CIRCADIAN HYPERGLYCEMIC DERANGEMENTS. | Glenn Veldscholte | ![]() |
![]() |
|||
POS-332 | HETEROGENEOUS INDICATIONS AND THE NEED FOR VIABILITY ASSESSMENT: RESULTS OF AN INTERNATIONAL SURVEY ON MACHINE PERFUSION IN LIVER TRANSPLANTATION | Davide Cussa | ![]() |
![]() |
|||
POS-333 | 2,4-DINITROPHENOL TREATMENT DURING NORMOTHERMIC MACHINE PERFUSION OF STEATOTIC HUMAN LIVERS; PHARMACOLOGICAL CONSIDERATIONS IN PERFUSION | Samuel Tingle | ![]() |
![]() |
|||
POS-334 | A MATCHED COMPARISON OF HYPOTHERMIC OXYGENATED MACHINE PERFUSION VS. COLD STORAGE IN LIVER TRANSPLANTATION | Franziskus Horodynski | ![]() |
![]() |
|||
POS-335 | HYPOTHERMIC OXYGENATED PERFUSION OF LIVER GRAFTS: A COST ANALYSIS | Stefania Camagni | ![]() |
![]() |
|||
POS-336 | ROLE OF D-HOPE RECONDITIONING OF LIVER GRAFTS FROM EXTENDED CRITERIA DBD DONORS | Paolo Magistri | ![]() |
![]() |
|||
POS-338 | ASSESSMENT OF MITOCHONDRIAL FUNCTION DURING PROLONGED EX VIVO LIVER NORMOTHERMIC MACHINE PERFUSION | Julia Hofmann | ![]() |
![]() |
|||
POS-341 | MEDICATION NON-ADHERENCE PREVALENCE AND DETERMINANTS IN CHILDREN AND ADOLESCENTS WITH CHRONIC LIVER DISEASES | Amirali Mashhadiagha | ![]() |
![]() |
|||
POS-342 | ARTERIAL AND BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION A SINGLE CENTER STUDY | Cristina Radu | ![]() |
![]() |
|||
POS-343 | INFLUENCE OF COVID19 PANDEMIC ON RECENTLY OPENED LIVER TRANSPLANTATION PROGRAMME IN GDANSK | Dariusz Laski | ![]() |
![]() |
|||
POS-345 | IS THERE A ROLE FOR INTENSIVE CARE IN LIVER TRANSPLANT ASSESSMENT? | Dhupal Patel | ![]() |
![]() |
|||
POS-347 | TREATMENT OF HEPATIC ARTERY OBSTRUCTION: THE LESSONS LEARNED IN A SERIES OF 2,478 LIVER TRANSPLANTS | fabio melandro | ![]() |
![]() |
|||
POS-348 | EARLY POST-OPERATIVE ANALGESIA FOLLOWING LIVER TRANSPLANT | Arturs Fedotovs | ![]() |
![]() |
|||
POS-349 | IS EARLY EXTUBATION AFTER LIVER TRANSPLANTATION FEASIBLE? | Sapna Sharma Hajela | ![]() |
![]() |
|||
POS-350 | IS ULTRASOUND AN UNNECESSARY BARRIER TO EARLY EXTUBATION AFTER LIVER TRANSPLANTATION? | Anna Shahid | ![]() |
![]() |
|||
POS-351 | PROXIMAL SPLENIC ARTERY EMBOLIZATION FOR REFRACTORY ASCITES AND HYDROTHORAX AFTER LIVER TRANSPLANT: A SINGLE CENTER EXPERIENCE | Luca Del Prete | ![]() |
![]() |
|||
POS-352 | LIVER TRANSPLANTATION FOR COVID-19-ASSOCIATED CHOLANGIOPATHY | Joris Blondeel | ![]() |
![]() |
|||
POS-353 | LDLT DURING COVID -19 PANDEMIC IN A SINGLE ROMANIAN TERTIARY REFERRAL CENTRE | Gabriela Smira | ![]() |
![]() |
|||
POS-356 | LIVER TRANSPLANTATION AND THE SEVENTH DAY SYNDROME: A SYSTEMATIC REVIEW OF THE LITERATURE AND CASE SERIES. | James Halle-Smith | ![]() |
![]() |
|||
POS-357 | AN ITALIAN SURVEY ON THE USE OF T-TUBE IN LIVER TRANSPLANTATION | Riccardo Pravisani | ![]() |
![]() |
|||
POS-359 | THE EFFECT OF PORTAL HYPERTENSION IN INTRAOPERATIVE BLEEDING DURING LIVER TRANSPLANTATION | Josep Martí Sanahuja Blasco | ![]() |
![]() |
|||
POS-360 | THE INFLUENCE OF SELECTED CRITERIA ON THE BILIARY COMPLICATIONS OCCURENCE | Katarzyna Biernat | ![]() |
![]() |
|||
POS-361 | PORTAL VEIN THROMBOSIS AND LIVER TRANSPLANTATION: RESULTS OF THE ITALIAN SOCIETY OF ORGAN TRANSPLANTATION NATIONAL SURVEY | Paolo Magistri | ![]() |
![]() |
|||
POS-362 | A PILOT STUDY OF A NON-INVASIVE REAL-TIME OPTICAL BACKSCATTER PROBE IN LIVER TRANSPLANTATION | James Richards | ![]() |
![]() |
|||
POS-364 | THE CHALLENGING MANAGEMENT OF VASCULAR RECONSTRUCTION IN LIVING DONOR LIVER TRANSPLANTATION THROUGH THE RECENT EXPERIENCE OF THE MODENA UNIVERSITY | Stefano Di Sandro | ![]() |
![]() |
|||
POS-365 | LIVER TRANSPLANT EXPERIENCES FOR THE BUDD-CHIARI SYNDROME AT BASKENT UNIVERSITY TRANSPLANT CENTERS | Emre KARAKAYA | ![]() |
![]() |
|||
POS-366 | CLINICAL OUTCOMES OF LIVER TRANSPLANTATION FOR PATIENTS OVER 60 YEARS OLD; A SINGLE CENTER EXPERIENCE | Aydincan Akdur | ![]() |
![]() |
|||
POS-367 | CAVOPORTAL HEMITRANSPOSITION ASSOCIATED TO PORTOPORTAL ANASTOMOSIS FOR LIVER TRANSPLANT IN PORTOMESENTERIC THROMBOSIS: HOW WE DO IT | Eugenia Rosso | ![]() |
![]() |
|||
POS-368 | LAPAROSCOPIC VS. LAPAROTOMIC LEFT LATERAL SECTIONECTOMY IN PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION | Sara Maritato | ![]() |
![]() |
|||
POS-370 | TECHNICAL REFINEMENTS TO THE RAPID TECHNIQUE: A POTENTIAL BREAKTHROUGH IN TRANSPLANT ONCOLOGY | Eugenia Rosso | ![]() |
![]() |
|||
POS-373 | POSTOPERATIVE TRENDS AND PROGNOSTIC VALUES OF INFLAMMATORY AND NUTRITIONAL BIOMARKERS AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA | Riccardo Pravisani | ![]() |
![]() |
|||
POS-374 | MELDING LOCOREGIONAL TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC) INTO LIVER TRANSPLANTATION PROGRAMME AT NEWLY FOUNDED CENTRE. | Krzysztof Graff | ![]() |
![]() |
|||
POS-375 | MODIFYING THE RETREAT SCORE TO PREDICT RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION | Monique Devillers | ![]() |
![]() |
|||
POS-377 | COMPLETE RESPONSE AFTER BIOLOGICAL DOWNSTAGING IN HEPATOCELLULAR CARCINOMA: XXL-LIKE PRIORITIZATION FOR TRANSPLANTATION OR WAITING AND SEE STRATEGY? | Alessandro Vitale | ![]() |
![]() |
|||
POS-378 | DE NOVO MALIGNANCY FOLLOWING LIVING DONOR LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE | Kohei Miura | ![]() |
![]() |
|||
POS-379 | ROBOTIC LIVER RESECTION FOR HCC AS A BRIDGE TO TRANSPLANTATION | Paolo Magistri | ![]() |
![]() |
|||
POS-380 | LONG-TERM OUTCOMES OF DE NOVO MALIGNANCY AFTER LIVER TRANSPLANTATION FOR ALCOHOLIC CIRRHOSIS | Marco Maria Pascale | ![]() |
![]() |
|||
POS-381 | IMMUNE CHECKPOINT AND IMMUNE CELL EXPRESSION IN THE TUMOR MICROENVIROMENT OF RESECTED HCC | Angeles Baquerizo | ![]() |
![]() |
|||
POS-384 | LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS: TIME TO EXTEND CRITERIA? | Marianna Maspero | ![]() |
![]() |
|||
POS-385 | DOWN-STAGING TREATMENT IMPROVEMENTS CHANGED THE PARADIGM OF LIVER TRANSPLANTATION FOR HCC | Enrico Prosperi | ![]() |
![]() |
|||
POS-386 | LIVER TRANSPLANTATION FOR HCC IN HIV PATIENTS: SINGLE CENTER EXPERIENCE | Marco Angelo Bongini | ![]() |
![]() |
|||
POS-387 | A RETROSPECTIVE SINGLE-CENTER ANALYSIS OF THE ONCOLOGICAL IMPACT OF LI-RADS CLASSIFICATION APPLIED TO METROTICKET 2.0 CALCULATOR: EVERY NODULE MATTERS | Leonardo Centonze | ![]() |
![]() |
|||
POS-389 | NEW STRATEGIES FOR THE MANAGEMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER COVID-19 PANDEMIC: A PROPOSAL FOR A NEW READY TO USE APP | Dario Quintini | ![]() |
![]() |
|||
POS-390 | THE IMPACT OF IMAGING AND PRE-TRANSPLANT TREATMENTS ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA | Daniele Dondossola | ![]() |
![]() |
|||
POS-391 | DOES NASH JEOPARDIZE LIVER TRANSPLANT SURVIVAL IN HCC PATIENTS? THE NIGUARDA EXPERIENCE | Fabio Ferla | ![]() |
![]() |
|||
POS-392 | TRANSPLANT BENEFIT AND URGENCY IN LUNG TRANSPLANTATION | Daniela Peritore | ![]() |
![]() |
|||
POS-393 | EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM EXCHANGES IN SARS-COV-2 PATIENTS AWAITING LUNG TRANSPLANT: LARGEST CASE SERIES FROM INDIA. | Vijil Rahulan | ![]() |
![]() |
|||
POS-395 | TOLERANCE OF ANTI-CMV PROPHYLAXIS WITH VALGANCICLOVIR ONE-YEAR TREATMENT IN D/R- LUNG TRANSPLANT PATIENTS. A SINGLE-CENTER RETROSPECTIVE STUDY | charlotte roy | ![]() |
![]() |
|||
POS-396 | A RANDOMIZED, MULTICENTER, BLINDED STUDY ASSESSING THE EFFECTS OF GASEOUS NITRIC OXIDE IN AN EX VIVO SYSTEM OF HUMAN LUNGS | Dana Torchia | ![]() |
![]() |
|||
POS-397 | LUNG BIOMOLECULAR PROFILE AND FUNCTION COMPARING GRAFT FROM MARGINAL BRAIN-DEAD DONORS AND DONORS AFTER CARDIAC DEATH | Jacopo Fumagalli | ![]() |
![]() |
|||
POS-398 | FEMALE RATS PRESENT HIGHER LUNG INFLAMMATION AFTER BRAIN DEATH FOLLOWED BY EX VIVO PERFUSION | Fernanda Yamamoto Ricardo da Silva | ![]() |
![]() |
|||
POS-399 | DONATION AFTER CARDIAC DEATH: A PERSPECTIVE FOR PEDIATRIC LUNG TRANSPLANTATION | Francesca Melosi | ![]() |
![]() |
|||
POS-400 | EFFECTS OF AZITHROMYCIN IN LUNG TRANSPLANT RECIPIENTS | Valeria Rossetti | ![]() |
![]() |
|||
POS-401 | SARS-COV-2 POSITIVE DONORS FROM NON-SUITABILITY TO THE USE FOR ORGAN TRANSPLANTATION | Federica Domini | ![]() |
![]() |
|||
POS-402 | UNINTERRUPTED AND SUCCESSFUL DECEASED PROGRAMME DURING THE COVID-19 CRISIS IN SLOVENIA | imenc Jana | ![]() |
![]() |
|||
POS-403 | INNATE INFLAMMATORY GENE EXPRESSION PROFILING IN POTENTIAL BRAIN-DEAD DONORS: DETAILED INVESTIGATION OF THE EFFECT OFCOMMON CORTICOSTEROID THERAPY | Sanaz Dehghani | ![]() |
![]() |
|||
POS-404 | NATIONAL DATASET ON DONATION AFTER CIRCULATORY DEATH AND BRAIN DEATH UNDER EXTRA-CORPOREAL SUPPORT: 3-YEAR ACTIVITY AND CRITICAL POINTS | Francesca Vespasiano | ![]() |
![]() |
|||
POS-405 | PROTOCOL FOR ORGAN OFFERS FROM ABROAD DURING THE COVID-19 PANDEMIC | Raffaele Donadio | ![]() |
![]() |
|||
POS-406 | A SINGLE CENTRE REVIEW OF THE DECEASED DONOR POPULATION IN A CARDIOTHORACIC INTENSIVE CARE OVER A 5 YEAR PERIOD | Aisling Mc Intyre | ![]() |
![]() |
|||
POS-407 | INTERNATIONAL REGISTRY IN ORGAN DONATION AND TRANSPLANTATION (IRODAT) 2019 VS 2020 WORLDWIDE DATA OVERVIEW | Marián Irazábal | ![]() |
![]() |
|||
POS-408 | ORGAN DONATION INNOVATIVE STRATEGIES FOR SOUTHEAST ASIA: ODISSEA | Maria Gomez | ![]() |
![]() |
|||
POS-409 | FIRST ITALIAN EXPERIENCE OF MOBILE ECMO TEAMS FOR CONTROLLED DONATION AFTER CIRCULATORY DEATH | Maria Adele Figini | ![]() |
![]() |
|||
POS-410 | LOSS OF SEROPROTECTION IN PATIENTS TRANSPLANTED FROM SOLID ORGANS PREVIOUSLY VACCINATED AGAINST HEPATITIS B | Lejeune Sophie | ![]() |
![]() |
|||
POS-411 | INVERTED DIRECT ALLORECOGNITION TRIGGERS EARLY DONOR SPECIFIC ANTIBODY RESPONSE AFTER TRANSPLANTATION | Xavier Charmetant | ![]() |
![]() |
|||
POS-412 | THE BLACK BOX OF IMMUNOSUPPRESSION AFTER SOLID ORGAN TRANSPLANTATION | Janne Kaes | ![]() |
![]() |
|||
POS-413 | DRUG TRANSPORTERS EXPRESSION IS ASSOCIATED WITH TACROLIMUS INTRACELLULAR CONCENTRATION | Florian Lemaitre | ![]() |
![]() |
|||
POS-414 | SMALL MOLECULE BCL6 INHIBITORS: A NEW DRUG CLASS OF IMMUNOSUPPRESSION FOR TRANSPLANTATION? | Louisa Steines | ![]() |
![]() |
|||
POS-415 | LACK OF INFORMATION IN RANDOMIZED CONTROLLED TRIALS TO GUIDE TRANSLATION OF MEDICATION ADHERENCE INTERVENTIONS TO CLINICAL PRACTICE: SYSTEMATIC REVIEW | Janette Ribaut | ![]() |
![]() |
|||
POS-416 | OUTCOMES OF SARS-COV-2 INFECTION IN PATIENTS UNDER PHARMACOLOGICAL IMMUNOSUPPRESSION: IS THERE ANY ADDITIONAL RISK? A SWISS COHORT STUDY. | Antonio Galante | ![]() |
![]() |
|||
POS-418 | FINGERPRICK SAMPLES FOR TACROLIMUS LEVELS DURING THE COVID-19 PANDEMIC: SINGLE CENTRE EXPERIENCE WITH HEART AND LUNG TRANSPLANT RECIPIENTS | Haifa Lyster | ![]() |
![]() |
|||
POS-419 | INCIDENCE OF STREPTOCOCCUS PNEUMONIAE AND HEMOPHILUS INFLUENZAE INFECTIONS IN ADULT SOLID ORGAN TRANSPLANT RECIPIENTS | Omid Rezahosseini | ![]() |
![]() |
|||
POS-420 | EARLY DETECTION OF EPSTEIN-BARR VIRUS (EBV) IN SOLID ORGAN TRANSPLANT RECIPIENTS. COMPARISON OF PCR FOR EBV DNA IN THREE DIFFERENT BLOOD COMPARTMENTS | Lene Ugilt Pagter Ludvigsen | ![]() |
![]() |
|||
POS-421 | THE CLINICAL OUTCOMES OF COVID-19 DISEASE IN PATIENTS WITH SOLID ORGAN TRANSPLANTATION | gaye ulubay | ![]() |
![]() |
|||
POS-422 | EVALUATION OF TRANSPLANTS PERFORMED IN ITALY WITH DONOR ORGANS WITH INFECTIOUS AND NEOPLASTIC RISK | Davide Stabile | ![]() |
![]() |
|||
POS-424 | IMPACT OF SARS-COV-2 INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS: THE REPORTING DATA AT THE END OF A DIFFICULT YEAR IN ITALY. | Silvia Trapani | ![]() |
![]() |
|||
POS-425 | THE IMPACT OF TRANSPLANT TYPE, AGE AND IMMUNOSUPPRESSION ON POST COVID-19 INFECTION SURVIVAL: A SINGLE CENTER UNITED STATES PROSPECTIVE COHORT STUDY. | Hailey Hardgrave | ![]() |
![]() |
|||
POS-427 | INTEREST IN AND EXPOSURE TO TRANSPLANT SURGERY AMONG MEDICAL STUDENTS AND TRAINEE DOCTORS | Diana Wu | ![]() |
![]() |
|||
POS-428 | eHealth delivered interventions for solid organ and hematopoietic stem cell transplantation recipients: A scoping review | Eleni Renaers | ![]() |
![]() |
|||
POS-430 | EUROPEAN INITIATIVES IN LIVING ORGAN DONATION PROGRAMS | Entela Kondi | ![]() |
![]() |
|||
POS-431 | PERCEPTIONS ON THE COVID-19 VACCINE: A PILOT STUDY | Fernando Yuen Chang | ![]() |
![]() |
|||
POS-432 | ORGAN DONATION AND TRANSPLANTATION DURING COVID-19 IN THE UK: CHALLENGES, LESSONS AND OPPORTUNITIES FOR FUTURE | Shivani Sharma | ![]() |
![]() |
|||
POS-433 | EVALUATING THE IMPACT OF CLINICAL LEADS FOR UTILISATION IN THE UNITED KINGDOM IN ADDRESSING NATIONAL AND LOCAL BARRIERS TO ORGAN TRANSPLANTATION | John Forsythe | ![]() |
![]() |
|||
POS-434 | SURVEY ON REGIONAL INITIATIVES SUPPORTING FOLLOWUP OF TRANSPLANTED PATIENTS DURING SARS-COV-2 PANDEMIC | Alessandra Oliveti | ![]() |
![]() |
|||
POS-435 | PILOT OBSERVATIONAL STUDY TO OBTAIN FEEDBACK ON MEDICATION COUNSELLING POST HEART & LUNG TRANSPLANT DURING THE COVID -19 PANDEMIC | Aanchal Grover | ![]() |
![]() |
|||
POS-436 | SOLID ORGAN TRANSPLANT RECIPIENTS RISK PERCEPTIONS, SHIELDING BEHAVIOUR AND PUBLIC TRUST DURING THE COVID-19 PANDEMIC | Angus Hann | ![]() |
![]() |
|||
POS-437 | T REGULATORY CELLS IN PATHOGENESIS OF CORNEAL GRAFT REJECTION | Justyna Sakowska | ![]() |
![]() |
|||
POS-438 | PANCREAS TRANSPLANTATION IN BLACK, ASIAN AND ETHNIC MINORITIES-A SINGLE CENTRE EXPERIENCE IN THE UK | Jeevan Gopal | ![]() |
![]() |
|||
POS-440 | WEIGHT GAIN FOLLOWING PANCREAS TRANSPLANTATION IN TYPE 1 DIABETES IS ASSOCIATED WITH A WORSEN GLYCEMIC PROFILE: A RETROSPECTIVE COHORT STUDY | Pedro Ventura Aguiar | ![]() |
![]() |
|||
POS-441 | THERE IS NO WEEKEND EFFECT IN PANCREAS TRANSPLANTATION | Ky-Leigh Ang | ![]() |
![]() |
|||
POS-442 | PATIENT EXPERIENCE IN PANCREAS TRANSPLANTATION A METHODOLOGICAL APPROACH TOWARDS INNOVATION IN AN ESTABLISHED PROGRAM | Pedro Ventura Aguiar | ![]() |
![]() |
|||
POS-443 | HEMOGLOBIN A1C AFTER PANCREAS-KIDNEY TRANSPLANTATION AS A PREDICTIVEMARKER FOR ENDOCRINE FUNCTION FAILURE IN PANCREATIC GRAFTS. | Emanuel Vigia | ![]() |
![]() |
|||
POS-444 | ENTERIC CONVERSION AFTER BLADDER-DRAINED KIDNEY-PANCREAS TRANSPLANTATION | Shobana Sivan | ![]() |
![]() |
|||
POS-445 | ENTERIC LEAK IN PANCREAS TRANSPLANTATION: COMPARING HAND-SEWN VS STAPLED ENTERIC ANASTOMOSES | Qingwei Zhang | ![]() |
![]() |
|||
POS-446 | SURGICAL COMPLICATIONS AFTER PANCREAS TRANSPLANTATION SINGLE CENTRE EXPERIENCE. | Pawel Skrzypek | ![]() |
![]() |
|||
POS-450 | DETECTING TISSUE DONORS IN A HOSPITAL EMERGENCY DEPARTMENT DURING COVID-19 PANDEMIC | Nuria Masnou Burralló | ![]() |
![]() |
|||
POS-451 | APPROACHING FAMILIES FOR ORGAN DONATION AUTHORISATION: HOW DO WE ASSESS A SOCIAL PROCESS? | Lissette Aviles | ![]() |
![]() |
|||
POS-452 | EXPERIENCE OF WELL-BEING AND MENTAL HEALTH AMONG TRANSPLANTED PATIENTS -A SYSTEMATIC LITERATURE REVIEW | Maria Ohm | ![]() |
![]() |
|||
POS-453 | IMPROVING IMMUNOSUPPRESSIVE MEDICATION ADHERENCE USING THE MARS-INTERVENTION: CASE STUDY ON ACHIEVING ENGAGEMENT AND ADHERENCE | Denise Beck | ![]() |
![]() |
|||
POS-454 | BILATERAL UPPER LIMB TRANSPLANTATION INCLUDING SHOULDER RECONSTRUCTION: Decision-making process and case presentation | Selma LAHLALI | ![]() |
![]() |
|||
POS-455 | MULTIFACETED APPROACH FOR DESENSITIZATION OF A HYPERIMMUNE HEART TRANSPLANTATION RECIPIENT | Denise Galbiati | ![]() |
![]() |
|||
POS-456 | A CASE OF CARDIAC TRANSPLANT COVID-19 - ASSOCIATED ACUTE MYOCARDITIS | Nadegda Koloskova | ![]() |
![]() |
|||
POS-457 | BARIATRIC SURGERY AFTER INTESTINAL TRANSPLANTATION IS SAFE AND EFFECTIVE. | Mathias Clarysse | ![]() |
![]() |
|||
POS-458 | NATIVE JEJUNAL CONDUIT FOR URINARY DIVERSION IN EN-BLOC LIVER-INTESTINE-KIDNEY TRANSPLANTATION | Luca Del Prete | ![]() |
![]() |
|||
POS-459 | RENAL TRANSPLANTATION IN GIGANTISM-A CASE REPORT AND REVIEW OF THE LITERATURE | Jeevan Gopal | ![]() |
![]() |
|||
POS-460 | LIVING-RELATED KIDNEY TRANSPLANTATION IN A PATIENT WITH JUVENILE NEPHRONOPHTHISIS | Ivana Dedinska | ![]() |
![]() |
|||
POS-462 | RENAL TRANSPLANTATION FROM A LIVING DONOR WITH RENAL ARTERY FIBROMUSCULAR DYSPLASIA | Paraskevi Andronikidi | ![]() |
![]() |
|||
POS-463 | RITUXIMAB IS EFFECTIVE IN TREATING KIDNEY ALLOGRAFT RECURRENT IGA NEPHROPATHY WITH NECROTIZING ARTERIOLITIS: A CASE REPORT | Nattawat Klomjit | ![]() |
![]() |
|||
POS-465 | ETANERCEPT-INDUCED LUPUS NEPHRITIS IN A KIDNEY TRANSPLANT RECIPIENT | Ivan Margeta | ![]() |
![]() |
|||
POS-466 | AB0 INCOMPATIBLE TRANSPLANTATION IN A PATIENT WITH COMPLEMENT DYSREGULATION: A DELICATE MATTER | Enrico Eugenio Minetti | ![]() |
![]() |
|||
POS-467 | DRUG INDUCED PURE RED CELL APLASIA IN RENAL TRANSPLANT RECIPIENT: CASE REPORT AND REVIEW OF LITERATURE. | Ayman Maher | ![]() |
![]() |
|||
POS-468 | SYNTHETIC ADRENOCORTICOTROPIC HORMONE A TREATMENT OPTION FOR POST RENAL TRANSPLANT RECURRENT RESISTANT PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS | Gauri Shankar Jagadesh | ![]() |
![]() |
|||
POS-469 | BELATACEPT AS MAINTENANCE THERAPEUTIC: AN ANSWER FOR DE NOVO THROMBOTIC MICROANGIOPATHY WITH ACUTE ANTIBODY-MEDIATED REJECTION | Mariana Sousa | ![]() |
![]() |
|||
POS-470 | THE FIRST REPORT OF HIV-POSITIVE KIDNEY TRANSPLANTATION IN THAILAND: PROVIDING THE OPPORTUNITY AND ACCESSIBILITY TO TRANPSLANTATION | Suwasin Udomkarnjananun | ![]() |
![]() |
|||
POS-471 | DISSEMINATED RHINOCLADIELLA MACKENZIEI INFECTION IN A KIDNEY TRANSPLANT RECIPIENT: CASE REPORT AND LITERATURE REVIEW. | Mohamed Zahab | ![]() |
![]() |
|||
POS-472 | SUCCESSFUL LIVE RELATED KIDNEY TRANSPLANT AFTER RECOVERY OF COVID-19 PNEUMONIA: CASE REPOT AND REVIEW OF LITERATURE. | osama Gheith | ![]() |
![]() |
|||
POS-475 | FOSCARNET INDUCED GENITAL LESIONS IN A KIDNEY TRANSPLANT RECIPIENT: A CASE REPORT. | Laura Diotallevi | ![]() |
![]() |
|||
POS-476 | PULMONARY MUCORMYCOSIS IN A KIDNEY TRANSPLANT RECIPIENT | Zdenek Lys | ![]() |
![]() |
|||
POS-477 | SUCCESSFUL TREATMENT OF TYPICAL HEMOLYTIC UREMIC SYNDROME IN A KIDNEY TRANSPLANT RECIPIENT USING ECULIZUMAB AND HAEMOADSORPTION DEVICES | Virginia Pronzo | ![]() |
![]() |
|||
POS-478 | STRONGYLOIDES STERCORALIS HYPERINFECTION SYNDROME IN A PATIENT UNDERGOING KIDNEY TRANSPLANT | LAURA LANCIONE | ![]() |
![]() |
|||
POS-479 | COVID-19 EARLY AFTER RENAL TRANSPLANTATION: LIMITATIONS AND HAZARDS OF UNPROVEN THERAPIES. | Concetta Cacace | ![]() |
![]() |
|||
POS-480 | KINETICS OF LYMPHOCYTE SUBSETS IN A RENAL RECIPIENT WITH CMV DISEASE TREATED WITH GANCYCLOVIR AND ANTI-CMV HYPERIMMUNE INTRAVENOUS IMMUNOGLOBULIN. | Javier Carbone | ![]() |
![]() |
|||
POS-481 | HERPES SIMPLEX VÍRUS-2 HEPATITIS FOLLOWING KIDNEY TRANSPLANT: TAKE A SECOND LOOK | Sara Fernandes | ![]() |
![]() |
|||
POS-482 | ALTERNARIA ALTERNATA PHAEOHYPHOMYCOSIS POST RENAL TRANSPLANT MASQUERADING AS CUTANEOUS TUMOUR | Laura Clementoni | ![]() |
![]() |
|||
POS-483 | MALAKOPLAKIA: A RARE CAUSE OF KIDNEY GRAFT DYSFUNCTION. | Cinthia Baldallo Moreno | ![]() |
![]() |
|||
POS-484 | THROMBOTIC MICROANGIOPATHY SECONDARY TO COVID-19 IN A RECENT ABO-INCOMPATIBLE KIDNEY TRANSPLANT RECIPIENT. | Zaira Ivette Castañeda Amado | ![]() |
![]() |
|||
POS-485 | IS THERE ANY ROOM FOR A CONSERVATIVE APPROACH FOR A GRAFT ARTERY ANEURISM? | Enrico Eugenio Minetti | ![]() |
![]() |
|||
POS-486 | REVERSIBLE ISCHEMIC NEPHROPATHY IN CADAVERIC RENAL TRANSPLANT RECIPIENT | osama Gheith | ![]() |
![]() |
|||
POS-487 | TREATMENT OF PSUEDOANEURISM OF EXTERNAL ILIAC ARTERY IN PATIENT UNDERGOING KIDNEY TRANSPLANT | LAURA LANCIONE | ![]() |
![]() |
|||
POS-488 | TIGECYCLINE-INDUCED ACUTE PANCREATITIS IN RENAL TRANSPLANT RECIPIENT: CASE REPORT AND REVIEW OF LITERATURE. | Ayman Maher | ![]() |
![]() |
|||
POS-489 | TRANSIENT HYPERPHOSPHATASEMIA IN AN ADOLESCENT AND AN ADULT RENAL TRANSPLANT PATIENT | Erasmia Sampani | ![]() |
![]() |
|||
POS-490 | A SUCCESSFUL KIDNEY AUTOTRANSPLANTATION IN A PATIENT WITH MULTIPLE RENAL ARTERY ANEURYSMS | Andriy Nykonenko | ![]() |
![]() |
|||
POS-491 | EN-BLOC KIDNEY TRANSPLANT USING AN AORTIC EXTENSION FROM A PAEDIATRIC MULTI-VISCERAL DONOR TO A PAEDIATRIC RECIPIENT. | Sergio Assia-Zamora | ![]() |
![]() |
|||
POS-492 | IS PREGNANCY SAFE IN THE EN BLOC RENAL RECIPIENTS FROM INFANT DONORS? A CASE REPORT | Zhendi Wang | ![]() |
![]() |
|||
POS-493 | WEST NILE ENCEPHALITIS IN AN ADOLESCENT KIDNEY TRANSPLANT RECIPIENT | Nikoleta Printza | ![]() |
![]() |
|||
POS-494 | ACQUIRED FACTOR VII DEFICINCY POST RENAL TRANSPLANTATION | Nihal Bashir | ![]() |
![]() |
|||
POS-495 | KIDNEY TRANSPLANTATION AS A TREATMENT OF CHOICE FOR AA AMYLOIDOSIS DUE TO PERIODIC FEVER SYNDROME | Ivana Dedinska | ![]() |
![]() |
|||
POS-496 | 50TH ANNIVERSARY OF THE FIRST KIDNEY TRANSPLANT IN BELARUS:SUCCESS PROGRAM HIGHLIGHTS AND CURRENT RESULTS | Aleh Kalachyk | ![]() |
![]() |
|||
POS-498 | THROW THE HEART OVER THE FENCE: SUCCESSFUL LIVING DONOR KIDNEY TRANSPLANT IN YOUNG MALE WITH SEVERE DISABILITY | Fausta Piancone | ![]() |
![]() |
|||
POS-501 | NEVER FORGET YOUR TRANSPLANT SURGERY IT COULD BE A LATE CAUSE OF ALLOGRAFT DYSFUNCTION | Filipa Ferreira | ![]() |
![]() |
|||
POS-502 | URETERIC TRAUMA FOLLOWING STENT REMOVAL IN KIDNEY TRANSPLANT RECIPIENT: A UNIQUE CASE OF PROLONGED MORBIDITY | AHMAD MIRZA | ![]() |
![]() |
|||
POS-503 | NOVEL MINIMALLY INVASIVE HYBRID APPROACH FOR TRANSPLANT URETERIC STENT EXCHANGES IN THE CONTEXT OF DIFFICULTY ACCESSING THEATRE DURING PANDEMIC | Robert Pearson | ![]() |
![]() |
|||
POS-505 | SYMPTOMATIC INCISIONAL HERNIA REPAIR POST KIDNEY TRANSPLANT: A SINGLE CENTRE EXPERIENCE | Laura Clementoni | ![]() |
![]() |
|||
POS-506 | RETROPERITONEOSCOPIC HAND-ASSISTED RIGHT NEPHRECTOMY IN LIVE DONOR WITH LEFT-SIDED INFERIOR VENA CAVA: CASE REPORT. | Carmelo Puliatti | ![]() |
![]() |
|||
POS-507 | MALIGNANT LYMPHOMA IN LIVING KIDNEY DONOR AND ITS RECIPIENT: THE DIAGNOSIS AFTER TRANSPLANTATION. | Concetta Cacace | ![]() |
![]() |
|||
POS-508 | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD): IS THE SECRET HIDDEN IN THE SPLEEN? | Ana Rodrigues | ![]() |
![]() |
|||
POS-509 | MERKELL CELL CARCINOMA AFTER KIDNEY TRANSPLANTATION | Andrea Bruno | ![]() |
![]() |
|||
POS-510 | GUILLAIN-BARRE SYNDROME CAUSED BY AN ALLOGRAFT RENAL CELL CANCER | Izabela Zakrocka | ![]() |
![]() |
|||
POS-513 | LIVER TRANSPLANTATION AFTER TAVI PREHABILITATION COMPLICATED BY CARDIAC ARREST, PULMONARY EMBOLISM AND STENOSIS OF IVC. | Aliaksei Shcherba | ![]() |
![]() |
|||
POS-515 | GRAFT VERSUS HOST DISEASE FOLLOWING LIVER TRANSPLANTATION A CLINICAL CASE | Aliki Xochelli | ![]() |
![]() |
|||
POS-516 | THE HIDDEN ENEMY BEHIND COVID-19 IN A RECENT LIVER TRANSPLANT PATIENT | Bianca Magro | ![]() |
![]() |
|||
POS-517 | LIVER TRANSPLANTATION IN RECIPIENTS WITH HISTORY OF AIDS-DEFINING CLINICAL CONDITIONS: IS IT POSSIBLE TO EXTEND THE INDICATIONS? | Matteo Ravaioli | ![]() |
![]() |
|||
POS-518 | TRANSPLANTATION OF A DISCARDED LIVER AFTER ISCHEMIA-FREE PROCUREMENT | Luca Del Prete | ![]() |
![]() |
|||
POS-519 | ATOVAQUONE INDUCED FULMINANT HEPATIC FAILURE IN LIVER TRANSPLANTATION | Virginia Ceccarossi | ![]() |
![]() |
|||
POS-520 | PROLONGED QT DURING ANAESTHESIA FOR PEDIATRIC CADAVERIC LIVER TRANSPLANTATION: A CASE REPORT | Ilaria Mascilini | ![]() |
![]() |
|||
POS-521 | CONTINUOUS RENAL REPLACEMENT THERAPY IN SMALL PEDIATRIC LIVER TRANSPLANT PATIENTS WITH ACUTE RENAL FAILURE | Dor Yoeli | ![]() |
![]() |
|||
POS-522 | APPLICATION OF AMPLTZER CARDIAC PLUG FOR FLOW MODULATION IN POST-TRANSPLANT PORTAL-STEAL SYNDROME FROM A SURGICAL LINTONS SPLENO-RENAL SHUNT | Leonardo Centonze | ![]() |
![]() |
|||
POS-523 | A CASE OF LIVER AUTOTRANSPLANTATION FOR GIGANTIC HEMANGIOMA WITH COAGULOPATHY | Ayato Obana | ![]() |
![]() |
|||
POS-525 | RESTORATION OF PORTAL INFLOW AFTER CAVOPORTAL HEMITRANSPOSITION IN A LIVER TRANSPLANT RECIPIENT WITH COMPLETE SPLANCHNIC THROMBOSIS | Mathias Clarysse | ![]() |
![]() |
|||
POS-526 | INTRALUMINAL BLEEDING FROM JEJUNAL ANASTOMOSIS STOPPED WITH INTRAOPERATIVE HAND ASSISTED ENTEROSCOPYAFTER ORTHOTROPIC LIVER TRANSPLANTATION | Krzysztof Graff | ![]() |
![]() |
|||
POS-527 | LIFE-SAVING LEFT RENAL VEIN LIGATION TO INTERRUPT SPONTANEOUS PORTOSYSTEMIC SHUNT AND RESTORE PORTAL VEIN FLOW AFTER SPLIT LIVER TRANSPLANTATION | Ivan Vella | ![]() |
![]() |
|||
POS-528 | PORTO-CAVAL SHUNT IN SPLIT LIVER TRANSPLANTATION: IS THERE ANY TIME LIMIT TO CLOSE IT? | Maria Fortuna Offi | ![]() |
![]() |
|||
POS-530 | A CASE OF SUCCESSFUL LIVER TRANSPLANTATION FROM DECEASED DONOR WITH BRAIN DEATH IN A PATIENT WITH RANDU-OSLER-WEBER DISEASE | Sergey Korotkov | ![]() |
![]() |
|||
POS-531 | LIVER TRANSPLANTATION FOR INTRAHEPATIC MASS-FORMING CHOLANGIOCARCINOMA FOLLOWING NEOADJUVANT CHEMOTHERAPY AND TRANS-HEPATIC RADIOEMBOLIZATION | Marianna Maspero | ![]() |
![]() |
|||
POS-532 | THE EFFECT OF PRE-TRANSPLANT LIPID PROFILE ON POST-TRANSPLANT HCC RECURRENCE | Volkan Ince | ![]() |
![]() |
|||
POS-534 | STENTING OF PULMONARY VEIN STENOSIS AFTER LOBAR LUNG TRANSPLANTATION: MINIMAL INVASIVE INTERVENTION TO AVOID GRAFT LOSS | Michaela Orlitova | ![]() |
![]() |
|||
POS-535 | DONOR-DERIVED TUBERCULOSIS IN LUNG TRANSPLANT RECIPIENT: THE NEED OF DONOR SCREENING | Renato Pascale | ![]() |
![]() |
|||
POS-537 | NEPHROTIC SYNDROME DUE TO NODULAR GLOMERULOSCLEROSIS IN A NON-DIABETIC LUNG TRANSPLANT RECIPIENT WITH CYSTIC FIBROSIS | Edith Renoult | ![]() |
![]() |
|||
POS-538 | NORMOTHERMIC EX-VIVO LUNG PERFUSION (EVLP) WITH PULMONARY ARTERY (PA) RECONSTRUCTION AFTER ITS MAIN TRUNK ACCIDENTAL DIVISION DURING HARVESTING | Elena Salvaterra | ![]() |
![]() |
|||
POS-539 | A LUNG TRANSPLANT PROGRAM SNAPSHOT AT THE TIME OF COVID-19: STILL EMERGENCY CASES FEASIBLE? | Elena Salvaterra | ![]() |
![]() |
|||
POS-540 | LUNG TRANSPLANT FOLLOWING COVID-19 INFECTION AFTER 6 MONTHS ON ECMO SUPPORT DEVELOPED SEVERE AMR POST TRANSPLANTATION | Sandra Lindstedt | ![]() |
![]() |
|||
POS-541 | A RARE CASE EVEROLIMUS-ASSOCIATED ALVEOLAR HEMORRAGE IN A KIDNEY TRANSPLANT RECIPIENT. | Marco Busutti | ![]() |
![]() |
|||
POS-542 | SYSTEMIZING GUIDELINES, MEMORANDA AND ROUTINES WITH ADDITIONAL CASE MEETINGS A TRANSPLANT COORDINATORS ON CALL BOOK AND A COORDINATORS CLUB | Caroline Stolt | ![]() |
![]() |
|||
POS-543 | SALVAGING GRAFT PANCREAS IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENT WITH SPLENIC ARTERY THROMBOSIS AND STENTING OF Y ARTERIAL GRAFT STENOSIS | Dr Devprakash Choudhary | ![]() |
![]() |
|||
POS-544 | EFFECTS OF COMPLETE IMMUNOSUPPRESSION SUSPENSION AFTER PANCREATIC GRAFT LOSS. | Emanuele Federico Kauffmann | ![]() |
![]() |
|||
POS-545 | THE FIRST EXPERIENCE OF RETROPERITONEAL TRANSPLANTATION OF THE DISTAL SEGMENT OF PANCREAS USING A PANCREATICOJEJUNAL ANASTOMOSIS ON A ROUX-EN-Y LOOP | Alexey Pinchuk | ![]() |
![]() |
|||
POS-546 | BEING AHEAD OF THE GAME. ORGAN OPTIMISATION PRIOR TO THE MOBILISATION OF A FULL CARDIOTHORACIC RETRIEVAL TEAM. THE NURSES EXPERIENCE. | Jen Baxter | ![]() |
![]() |
|||
POS-547 | NURSING MANAGEMENT IN POST-OPERATIVE PEDIATRIC LIVER TRANSPLANTATION: OUR EXPERIENCE | Elisabetta Rossetto | ![]() |
![]() |
|||
POS-548 | MAINTAINING AND DELIVERING A WORLD CLASS EDUCATION SERVICE TO SPECIALIST NURSES IN ORGAN DONATION DURING A PANDEMIC | Susan Lee | ![]() |
![]() |
|||
POS-549 | ALEMTUZUMAB INDUCTION ALLOWS THE EFFECTIVE USE OF CYCLOSPORINE A IN STEROID-FREE REGIMES OF IMMUNOSUPPRESSIVE TREATMENT AFTER KIDNEY TRANSPLANTATION | Aleh Kalachyk | ![]() |
![]() |
|||
POS-730 | THE STATE OF INTERSTITIAL GLUCOSE METABOLISM IN DECEASED DONOR LIVER DURING STATIC COLD STORAGE MAY PREDICT ORGAN VIABILITY AND INITIAL GRAFT FUNCTION | Alexander Sushkov | ![]() |
![]() |
|||
POS-732 | THE ROLE OF HLA ANTIGENTS ON COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS | Ivana Dedinska | ![]() |
![]() |
|||
POS-735 | USABILITY OF AN INTERACTIVE HEALTH TECHNOLOGY FOR KIDNEY LIVING DONORS ASSESSMENT: TOWARDS A STANDARDIZED INFORMED PROCESS | Fernanda Ortiz | ![]() |
![]() |
|||
POS-737 | INFLUENCE OF IMMUNOSUPPRESSIVE DRUG TROUGH LEVELS ON NK CELLS IN LIVER TRANSPLANTATION | Rongrong Qin | ![]() |
![]() |
|||
POS-741 | THE PARADOX EFFECT OF PRE-TRANSPLANT LOCO-REGIONAL THERAPIES ON CANCER RELATED DEATH AFTER LIVER TRANSPLANTION FOR HCC | Jacopo Lanari | ![]() |
![]() |
|||
POS-742 | THE USEFULNESS OF CONTRAST-ENHANCED ULTRASOUND IN PREDICTING THE OUTCOME OF KIDNEY TRANSPLANTS | Valentina Iori | ![]() |
![]() |
|||
POS-743 | A clinical lifestyle dashboard using routine clinical care data to improve kidney transplantation care | jip van den berg | ![]() |
![]() |
|||
POS-744 | TOWARDS ROUTINE SURVEILLANCE OF KIDNEY ALLOGRAFT REJECTION USING A FULLY AUTOMATED URINARY CXCL9 AND CXCL10 IMMUNOASSAY AND A WEB APPLICATION | Claire Tinel | ![]() |
![]() |
|||
POS-746 | OUTCOMES OF AKI IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19 INFECTION: A TRAINEE-LED, MULTICENTRE, INTERNATIONAL REGISTRY STUDY | Matthew Bottomley | ![]() |
![]() |
|||
POS-747 | PREDICTORS OF OUTCOMES IN COVID-19 POSITIVE ABDOMINAL ORGAN TRANSPLANT | Aaron Ahearn | ![]() |
![]() |
|||
POS-748 | HEART TRANSPLANTATION FROM CONTROLLED DONATION AFTER THE CIRCULATORY DETERMINATION OF DEATH USING THORACO-ABOMINAL NORMOTHERMIC REGIONAL PERFUSION. | Jose Moya Sanchez | ![]() |
![]() |
|||
POS-749 | TRANSFORMING GROWTH FACTOR BETA 1 GENE POLYMORPHISM IN PEDIATRIC LIVER RECIPIENTS | Rivada Kurabekova | ![]() |
![]() |
|||
POS-750 | COMPARING PHYSICAL AND PSYCHOSOCIAL OUTCOMES IN UNSPECIFIED VS. SPECIFIED KIDNEY DONORS AT 3 MONTHS AFTER DONATION: RESULTS FROM THE UK BOUND STUDY | Hannah Maple | ![]() |
![]() |
|||
POS-752 | FACTORS INFLUENCING ACCESS TO KIDNEY TRANSPLANTATION (FIAT): FIRST RESULTS OF STAKEHOLDERS PERSPECTIVE | Ruben van Merweland | ![]() |
![]() |
|||
POS-753 | OPINIONS ON COVID-19 VACCINATION IN TRANSPLANTATION: RESULTS OF A NATIONAL SURVEY | Bynvant Sandhu | ![]() |
![]() |
|||
POS-754 | NEOPLASTIC LESIONS IN TRANSPLANTED PATIENTS: THE CANCER GENESIS | Federica Masci | ![]() |
![]() |
|||
POS-755 | NON-HLA ANTIBODY STUDY IN ANTIBODY-MEDIATED REJECTION IN A SPANISH MULTICENTER COHORT | David San Segundo Arribas | ![]() |
![]() |
|||
POS-756 | THE SMALL-MOLECULE BCL6-INHIBITOR 79-6 SUPPRESSES FOLLICULAR T HELPER CELL DIFFERENTIATION AND PLASMA BLAST FORMATION | Rens Kraaijeveld | ![]() |
![]() |
|||
POS-757 | A SINGLE-CENTRE ANALYSIS OF ELDERLY (=70 YEARS) DONATION AFTER CIRCULATORY DEATH (DCD) KIDNEY TRANSPLANT OUTCOMES | Susanna Lam | ![]() |
![]() |
|||
POS-758 | FAMILY BEREAVEMENT AND ORGAN DONATION. A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY IN ANDALUSIA | María Victoria Martínez López | ![]() |
![]() |
|||
POS-761 | EVEROLIMUS IN HEART RECIPIENTS FOR PROTECTING RENAL FAILURE: A SINGLE-CENTER RUSSIAN EXPERIENCE | Nadegda Koloskova | ![]() |
![]() |
|||
POS-762 | THE IMPACT OF INTRA-ABDOMINAL HYPERTENSION AFTER LIVER TRANSPLANTATION IN ADULT PATIENTS | Ivan Vella | ![]() |
![]() |
|||
POS-763 | STEATOTIC LIVER ALLOGRAFTS APPEAR TO INCREASE THE RISK OF POSTOPERATIVE SEVERE KIDNEY INJURY REQUIRING CONTINUOUS VENO-VENOUS HEMOFILTRATION | Remo Alessandris | ![]() |
![]() |
|||
POS-766 | ABSENCE OF RESUSCITATION DURING NORMOTHERMIC REGIONAL PERFUSION USING A PORTABLE GAMMA-CAMERA SYSTEM | José Moya Sánchez | ![]() |
![]() |
|||
POS-767 | GENETIC VARIABILITY IN GLUCOCORTICOID PATHWAY AND NEW ONSET DIABETES MELLITUS AFTER TRANSPLANTATION | Gregor Mlinsek | ![]() |
![]() |
|||
POS-768 | DECIPHERING BIOLOGICAL DETERMINANTS OF PREFORMED T AND B-CELL ALLOSENSITIZATION IN KIDNEY TRANSPLANT CANDIDATES | VINCENT PERNIN | ![]() |
![]() |
|||
POS-771 | PROSPECTIVE ASSESSMENT OF GRAFT RECOVERY AFTER KIDNEY TRANSPLANTATION BY MEANS OF DONOR-DERIVED CELL-FREE DNA | David Cucchiari | ![]() |
![]() |
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|